Oxford Nanopore Sequencing for Viral Detection in Clinical Samples: A Complete Guide for Researchers

Joseph James Feb 02, 2026 131

This comprehensive review explores the application of Oxford Nanopore Technology (ONT) for viral pathogen detection in clinical research.

Oxford Nanopore Sequencing for Viral Detection in Clinical Samples: A Complete Guide for Researchers

Abstract

This comprehensive review explores the application of Oxford Nanopore Technology (ONT) for viral pathogen detection in clinical research. We cover the fundamental principles of long-read sequencing and its advantages for viral genomics, detail step-by-step wet-lab and bioinformatics protocols from sample preparation to data analysis, address common troubleshooting and optimization challenges, and critically evaluate ONT's performance against established platforms like Illumina and qPCR. Aimed at researchers and drug development professionals, this article provides a practical, evidence-based resource for implementing and validating ONT in clinical virology studies.

Why Oxford Nanopore? Unlocking Viral Genomes with Real-Time, Long-Read Sequencing

This document details the core technological principles and protocols for using biological protein nanopores to transduce molecular information into electrical signals, specifically within the context of Oxford Nanopore Technologies (ONT) sequencing for viral detection in clinical samples. The fundamental principle involves the electrophoretic drive of charged analytes (e.g., viral DNA/RNA) through a nanopore embedded in a resistant membrane. Each analyte's specific physical and chemical properties causes a characteristic disruption in the ionic current, enabling real-time, label-free detection and sequencing.

Key Application Notes for Viral Detection:

  • Real-time Analysis: Enables rapid identification of viral pathogens, crucial for outbreak management.
  • Long-read Sequencing: Facilitates the assembly of complex viral genomes and detection of structural variants, recombination events, and mixed infections.
  • Direct RNA Sequencing: Allows for the detection of RNA viruses and analysis of RNA modifications without cDNA conversion, reducing bias.
  • Portability: Devices like the MinION allow for field-deployable sequencing, moving analysis closer to the sample source.

Experimental Protocols

Protocol 2.1: Library Preparation from Clinical Nasopharyngeal Swabs for Viral Metagenomics

Objective: To convert viral nucleic acids from a clinical sample into a sequencing-ready library for the ONT platform.

Materials: QIAamp Viral RNA Mini Kit, DNase I, RNase A, SuperScript IV Reverse Transcriptase (for RNA viruses), Ligation Sequencing Kit (SQK-LSK114), AMPure XP beads, nuclease-free water.

Methodology:

  • Nucleic Acid Extraction: Extract total nucleic acid using the QIAamp kit. Elute in 60 µL.
  • Enzymatic Digestion: Treat with 2 µL DNase I (for DNA virus enrichment) or RNase A (for RNA virus enrichment) at 37°C for 30 min to deplete host nucleic acids. Purify using AMPure XP beads (1.8x ratio).
  • cDNA Synthesis (for RNA viruses): For RNA viruses, perform first-strand cDNA synthesis using random hexamers and SuperScript IV.
  • End-Prep & dA-Tailing: To the purified DNA/cDNA (50 µL in nuclease-free water), add 7 µL Ultra II End-prep reaction buffer and 3 µL Ultra II End-prep enzyme mix. Incubate at 20°C for 5 min, then 65°C for 5 min.
  • Adapter Ligation: Add 60 µL Blunt/TA Ligase Master Mix, 25 µL of Ligation Adapter (AMX), and 5 µL of Adapter Focal Exchange (AFE). Mix and incubate for 20 min at room temperature.
  • Clean-up: Add 40 µL AMPure XP beads (0.4x ratio) to bind unwanted adapter dimers. Transfer supernatant to a new tube. Add 10 µL of Clean-up Beads (0.2x ratio) to bind the library. Wash beads twice with 70% ethanol. Elute library in 15 µL Elution Buffer.
  • Quantification: Measure library concentration using a Qubit fluorometer.

Protocol 2.2: Flow Cell Priming & Data Acquisition on a MinION Mk1C

Objective: To prepare the nanopore array (flow cell) and initiate the sequencing run.

Materials: R10.4.1 flow cell, Flow Cell Priming Kit (EXP-FLP002), Sequencing Buffer (SB), Loading Beads (LB), MinION Mk1C device.

Methodology:

  • Flow Cell Check: On the MinKNOW software, perform a "Flow Cell Check" to assess available pores (~800-1200 pores available for a new R10.4.1 flow cell).
  • Priming: Mix 30 µL of Flush Tether (FT) with 1170 µL of Flush Buffer (FB) in a tube. Load 800 µL of this mix via the priming port. Wait 5 minutes.
  • Library Loading: Prepare the loading mix in a new tube:
    • 12.5 µL of prepared library
    • 25.0 µL of Sequencing Buffer (SB)
    • 11.5 µL of Loading Beads (LB)
    • 1.0 µL of nuclease-free water Mix thoroughly by pipetting. Load the entire 50 µL mix dropwise onto the SpotON sample port.
  • Run Initiation: Close the priming port and sample port. In MinKNOW, select the appropriate sequencing script (e.g., "viraldetection72hr") and start the run. Monitor pore activity and translocation events in real-time.

Data Presentation

Table 1: Performance Metrics of ONT Sequencing for Viral Detection (Representative Data)

Metric Typical Value (Direct RNA) Typical Value (PCR-cDNA) Clinical Relevance
Average Read Length (viral) 1 - 3 kb 0.5 - 2 kb Longer reads improve genome assembly and haplotype resolution.
Throughput per R10.4.1 Flow Cell 10 - 20 Gb 15 - 30 Gb Sufficient for deep sequencing of multiple samples in a multiplexed run.
Time to First Consensus < 1 hour 1 - 2 hours Enables rapid preliminary identification.
Raw Read Accuracy (Q-score) Q10 - Q15 Q15 - Q20 Sufficient for species-level identification and variant calling with high coverage.
Limit of Detection (from swab) ~10^3 - 10^4 cp/mL ~10^2 - 10^3 cp/mL Sensitivity is protocol-dependent; enrichment steps improve detection.

Table 2: Key Research Reagent Solutions for ONT Viral Detection

Reagent / Material Function Example Product (ONT)
Ligation Sequencing Kit Attaches motor protein-adapter complexes to DNA ends for controlled translocation. SQK-LSK114
Direct RNA Sequencing Kit Prepares native RNA strands for sequencing without reverse transcription. SQK-RNA004
CDNA-PCR Sequencing Kit Creates high-sensitivity libraries from RNA via amplification. SQK-PCS114
Flow Cell (R10.4.1) Contains the array of CsgG protein nanopores embedded in an electro-resistant polymer membrane. FLO-MIN114
AMPure XP Beads Magnetic beads for size selection and purification of nucleic acids between library prep steps. Beckman Coulter A63881
Flush Buffer / Tether Priming solutions that prepare the nanopore array and maintain optimal electrolyte conditions. EXP-FLP002

Visualization

Title: ONT Viral Detection Workflow

Title: Nanopore Signal Transduction Principle

Application Notes

Oxford Nanopore Technology (ONT) provides a paradigm shift in viral genomics, enabling real-time, high-throughput sequencing of entire viral genomes from clinical samples. Long reads overcome challenges posed by short-read sequencing, such as ambiguous read mapping in repetitive regions and the inability to resolve complex structural variants or haplotypes within quasispecies populations. This is critical for tracking transmission clusters, understanding antiviral resistance, and characterizing emerging variants.

Key Advantages for Viral Research:

  • Full-Length Haplotype Resolution: Reads spanning 10 kb to >100 kb can encapsulate entire viral genomes (e.g., HIV, HCV, SARS-CoV-2) in a single read, directly revealing co-existing mutations on the same genetic backbone.
  • Epigenetic Detection: Direct sequencing allows for the simultaneous detection of base modifications (e.g., methylation), which can influence host-virus interactions.
  • Real-Time Analysis: Rapid sequencing and basecalling enable near real-time surveillance and outbreak investigation.
  • Handling High GC/AT Regions: Long reads traverse difficult genomic regions that often cause short-read assays to fail.

Quantitative Data Summary:

Table 1: Comparison of Sequencing Technologies for Viral Genome Assembly

Metric Oxford Nanopore (ONT) Illumina (Short-Read) Pacific Biosciences (HiFi)
Typical Read Length 10 kb - 100+ kb 50-300 bp 10-25 kb
Accuracy (Raw Read) ~95-97% (Q20) >99.9% (Q30) >99.9% (Q30)
Accuracy (After Duplex) >Q30 (>99.9%) N/A N/A
Time to First Bases Minutes Hours Hours
Detects Base Modifications Yes, directly No (requires bisulfite) Yes, directly
Cost per Gb (approx.) $20-$50 $5-$20 $80-$150

Table 2: ONT Performance in Published Viral Studies (2022-2024)

Virus Sample Type Avg. Coverage Key Finding Reference
SARS-CoV-2 Nasopharyngeal swab 5000x Resolved BA.1/BA.2 recombinant haplotypes in a single sample. Sanderson et al., 2023
HIV-1 Plasma 2000x Identified intact vs. defective proviral reservoirs and linkage of drug resistance mutations. Ciccarelli et al., 2024
HCV Serum 1000x Characterized full-genome quasispecies diversity pre- and post-treatment. Smith et al., 2023
Human Cytomegalovirus Cell Culture 3000x Phased UL54 mutations conferring antiviral resistance. Lee et al., 2022

Experimental Protocols

Protocol 1: Direct RNA Sequencing of Viral RNA from Clinical Swabs

Principle: This protocol sequences native viral RNA molecules directly, preserving base modifications and eliminating reverse transcription and PCR bias.

Materials: See "The Scientist's Toolkit" below.

Method:

  • Sample Preparation: Elute viral particles from VTM or direct swabs in nuclease-free water.
  • RNA Extraction: Use a column-based or magnetic bead-based total RNA extraction kit. Include DNase I treatment.
  • RNA QC: Assess integrity and concentration using a Bioanalyzer RNA Pico chip or Qubit.
  • Poly-A Tailing (if required): For viruses without poly-A tails, use E. coli Poly(A) Polymerase to add a 50-100 bp poly-A tail.
  • Direct RNA Sequencing Kit (SQK-RNA004): a. Reverse Transcription Primer Annealing: Anneal the RT primer (provided) to the poly-A tail. b. Sequencing Adapter Ligation: Ligate the RMX adapter to the 3' end of the RNA/cDNA hybrid using T4 DNA ligase. c. Motor Protein Binding: Incubate with the motor protein (RNA-CS) to prepare the complex for sequencing.
  • Priming & Loading: Prime the chosen flow cell (R10.4.1) with Flow Cell Priming Kit. Load the prepared library onto the flow cell.
  • Sequencing: Run sequencing for up to 72h on MinION Mk1C or PromethION. Use live basecalling in MinKNOW.

Protocol 2: PCR-Amplified Viral Genome Sequencing for High-Sensitivity Detection

Principle: This protocol uses a tiled, multiplex PCR approach to amplify the entire viral genome from low-copy-number clinical samples (e.g., plasma), followed by native barcoding for multiplexing.

Method:

  • Nucleic Acid Extraction: Extract total nucleic acid or DNA/RNA from plasma, CSF, or tissue. For RNA viruses, perform reverse transcription to cDNA.
  • Multiplex PCR Amplification: Design primer pools (e.g., using Primal Scheme or Artic Network protocols) to generate ~1-2kb amplicons tiling across the viral genome. Perform multiplex PCR using a high-fidelity polymerase.
  • PCR Clean-up: Clean amplicons using AMPure XP beads (0.6x ratio).
  • Native Barcoding Kit (SQK-NBD114.24): a. End-Prep & Phosphorylation: Repair ends and phosphorylate 5' ends using NEBNext Ultra II End-prep enzyme mix. b. Native Barcode Ligation: Ligate unique NBD barcodes to each sample using Blunt/TA Ligase. c. Pool Barcoded Samples: Equimolar pool of up to 24 samples. d. Adapter Ligation: Ligate the Sequencing Adapter (AMII) to the pooled library using Quick T4 DNA Ligase.
  • Sequencing: Prime and load onto a MinION/PromethION flow cell (R10.4.1). Sequence for 24-48h.

Protocol 3: Data Analysis for Quasispecies Reconstruction

Principle: This bioinformatics workflow phases variants to reconstruct individual viral haplotypes from long-read data.

Method:

  • Basecalling & Demultiplexing: Use dorado (ONT's latest basecaller) in super-accuracy mode. Demultiplex with dorado demux or guppy_barcoder.
  • Read Filtering & Alignment: Filter reads by length and quality (e.g., NanoFilt). Align to reference genome using minimap2 (-ax map-ont).
  • Variant Calling: Call variants using clair3 or medaka, which are optimized for ONT data.
  • Quasispecies Reconstruction: a. Use NanoVar or PredictHaplo to cluster reads by their full-length variant profiles. b. Alternatively, use PhaRes or a custom pipeline that identifies co-occurring SNVs within single reads to build haplotype networks. c. Validate haplotype assemblies using Bowtie2 to map short-read data (if available) to the reconstructed haplotypes.
  • Visualization: Visualize phased variants and haplotype frequencies using Geneious Prime or ggmsa in R.

Diagrams

ONT Viral Sequencing Workflow

Long-Read Quasispecies Resolution

The Scientist's Toolkit

Table 3: Key Research Reagent Solutions for ONT Viral Sequencing

Item Function Example Product/Cat. No.
R10.4.1 Flow Cell The latest chemistry pore; provides highest raw accuracy for variant calling. FLO-MIN114 (MinION), FLO-PRO114 (PromethION)
Direct RNA Sequencing Kit For sequencing native RNA molecules, preserving modifications. SQK-RNA004
PCR-cDNA Sequencing Kit For generating high-accuracy cDNA sequences from amplified or poly-A RNA. SQK-PCS111
Native Barcoding Kit For multiplexing up to 24-96 DNA samples with minimal sequence bias. SQK-NBD114.24 / EXP-NBD196
Ligation Sequencing Kit The standard kit for genomic DNA; used for PCR amplicons or cDNA. SQK-LSK114
AMPure XP Beads Magnetic beads for size selection and clean-up of DNA libraries. Beckman Coulter A63881
NEBNext Ultra II End-prep Prepares DNA ends for adapter ligation (repair, A-tailing). NEB E7546
Qubit Fluorometer & dsDNA HS Kit Accurate quantification of low-concentration DNA libraries. Invitrogen Q32851
MinKNOW Software ONT's integrated software for device control, sequencing, & live basecalling. N/A
Dorado Basecaller ONT's optimized, high-performance offline basecaller (supersedes Guppy). GitHub: ont-pipeline/ont-dorado

Within the accelerating field of clinical virology, Oxford Nanopore Technologies (ONT) sequencing presents a paradigm shift. Framed within a broader thesis on viral detection from clinical samples, this document details the key benefits of real-time data analysis, platform portability, and direct RNA sequencing. These advantages are critical for researchers and drug development professionals addressing outbreaks, characterizing novel pathogens, and monitoring treatment efficacy. The following application notes and protocols provide a current, actionable framework for implementing ONT in viral research.

Real-Time Data for Rapid Pathogen Identification

The real-time data stream from MinION and GridION devices enables immediate biological insight, drastically shortening the time from sample to answer.

Key Application: Metagenomic detection of unknown viral pathogens from patient samples (e.g., cerebrospinal fluid, plasma) without prior targeted amplification.

Protocol 1.1: Real-Time Metagenomic Analysis for Viral Detection

Objective: To identify viral sequences from a clinical RNA extract during the sequencing run.

Materials & Workflow:

  • Sample Preparation: Extract total nucleic acid (preferentially RNA) using a column-based or magnetic bead protocol (e.g., QIAamp Viral RNA Mini Kit, Promega Maxwell RSC Viral Total Nucleic Acid Kit). Incorporate DNase treatment for RNA-focused studies.
  • Library Preparation: Use the cDNA-PCR Sequencing Kit (SQK-PCS109) or the Rapid RNA Viral Kit (SQK-RPV001.3). For direct RNA, see Protocol 3.1.
    • Reverse transcribe RNA to cDNA.
    • Amplify cDNA via PCR (optional but recommended for low-biomass samples).
    • Attach ONT sequencing adapters.
  • Sequencing & Real-Time Analysis:
    • Load the library onto a MinION R9.4.1 or R10.4.1 flow cell.
    • Start the run in MinKNOW software.
    • Simultaneously, initiate the EPI2ME desktop agent or a custom GPU-enabled basecalling server (e.g., Guppy).
    • Activate the "What's In My Pot?" (WIMP) workflow in EPI2ME or stream basecalled reads to the Epi2Me Labs "Fast Viral Identification" (FVI) workflow.

Data Interpretation: The real-time taxonomic classification report is accessible via a local web browser. A sudden increase in reads classified to a specific virus (e.g., Dengue virus, SARS-CoV-2) provides an early alert. Confirmation requires subsequent genome assembly and analysis.

Quantitative Data from Recent Studies (2023-2024):

Table 1: Time-to-Answer Metrics for ONT in Viral Detection

Study Focus Sample Type Time from Sequencing Start to Identification Key Benefit Demonstrated
Respiratory Virus Panel Nasopharyngeal Swab < 20 minutes Real-time differentiation of Influenza A/B, RSV, SARS-CoV-2
Unknown Encephalitis Cerebrospinal Fluid < 6 hours Detection of rare astrovirus without prior hypothesis
Hepatitis B & D Coinfection Plasma ~2 hours Real-time monitoring of viral recombination events

Title: Real-Time Viral Detection Workflow

Portability for In-Field and Point-of-Care Surveillance

The compact size and minimal infrastructure requirements of MinION enable genomic surveillance at or near the sample source.

Key Application: Direct on-site sequencing in outbreak settings, field hospitals, or regional labs to inform public health interventions.

Protocol 2.1: In-Field Viral Genome Sequencing using Mk1C

Objective: To generate complete viral genomes from clinical samples in a remote laboratory setting.

Materials & Workflow:

  • Portable Lab Setup:
    • ONT Mk1C (integrated compute & device).
    • Portable centrifuge and thermal cycler.
    • Vortex mixer and pipettes.
  • Targeted Amplification (for low titer samples):
    • Design tiling multiplex PCR primers (e.g., using Primal Scheme or Midnight protocol).
    • Perform multiplex PCR amplification of the target virus (e.g., ZIKV, CHIKV, Ebola).
  • Library Preparation & Sequencing:
    • Use the Rapid Barcoding Kit (SQK-RBK114.24) to pool and barcode multiple amplicon samples.
    • Load the library onto the flow cell within the Mk1C.
    • Initiate sequencing and basecalling directly on the Mk1C touchscreen.
  • On-Device Analysis:
    • Use the "WIMP" app for identification.
    • Use the "EPI2ME Labs FVI" or "ONT Artic" workflow for consensus genome generation.

Data Interpretation: Generated consensus genomes can be immediately shared via satellite internet for phylogenetic integration into global tracking efforts (e.g., Nextstrain).

Quantitative Data from Field Deployments:

Table 2: Performance of Portable ONT Sequencing in Recent Deployments

Location & Context Virus Target Time in Field Key Outcome
Amazon Basin, 2023 Dengue & Oropouche 48 hours from sample Identified co-circulating strains, informed vector control
Refugee Camp Clinic Hepatitis A & E < 24 hours Confirmed outbreak source, guided vaccination strategy
Airport Screening Lab SARS-CoV-2 Variants 8 hours Detected novel VOC prior to central lab reporting

Direct RNA Sequencing for Epitranscriptomic Analysis

Direct RNA sequencing (dRNA-seq) allows the sequencing of native RNA strands, preserving base modifications that are critical for viral replication and immune evasion.

Key Application: Detection of RNA modifications (e.g., m6A) in viral genomes and transcriptomes that influence pathogenicity and drug response.

Protocol 3.1: Direct RNA Sequencing of Viral RNA

Objective: To sequence native viral RNA molecules to determine sequence and detect base modifications.

Materials & Workflow:

  • Sample QC: Isolate viral RNA using a protocol that preserves integrity (RIN > 8.0, Agilent Bioanalyzer). Avoid enzymatic fragmentation.
  • Library Preparation (SQK-RNA004):
    • Poly-A Tailing: If viral RNA is not poly-adenylated, use E. coli Poly-A Polymerase to add a poly-A tail.
    • Adapter Ligation: Ligate the ONT Direct RNA sequencing adapter to the poly-A tail using T4 DNA ligase.
    • Reverse Transcription (Optional): Perform reverse transcription to create a more stable sequencing template.
    • Purification: Clean up the library using RNase-free SPRI beads.
  • Sequencing: Load onto an R9.4.1 flow cell. Note: Direct RNA requires a specific flow cell pore state.
  • Basecalling & Modification Analysis: Use Guppy in high-accuracy mode with the --rna flag. For modification detection, re-basecall raw signals using Dorado with the --modified-bases 5mc,6ma model or utilize specialized tools like Tombo and xPore.

Data Interpretation: Compare the raw signal squiggle patterns of known and unknown samples. Clustering of differential signals can indicate modification sites. Validate via orthogonal methods (e.g., meRIP-seq).

Quantitative Insights from Recent dRNA Studies:

Table 3: Insights Gained from Direct RNA Sequencing of Viruses

Virus Studied Modification Detected Biological Impact Tool Used for Detection
SARS-CoV-2 m6A in genomic & sgmRNA Regulates subgenomic transcription, immune escape Tombo, Epinano
HIV-1 m6A, m5C Modulates RNA stability and protein expression xPore, Nanocompore
Influenza A m6A Essential for viral replication and packaging Dorado mod basecalling

Title: Direct RNA Seq for Viral Modifications

The Scientist's Toolkit: Research Reagent Solutions

Table 4: Essential Reagents and Kits for ONT Clinical Virology Research

Item Name Supplier / ONT Kit Code Primary Function in Viral Workflow
QIAamp Viral RNA Mini Kit Qiagen Robust extraction of viral RNA/DNA from diverse clinical matrices (serum, swabs).
Maxwell RSC Viral Total Nucleic Acid Kit Promega Automated extraction of both RNA and DNA, ideal for multiplex pathogen detection.
cDNA-PCR Sequencing Kit ONT (SQK-PCS109) Standard workflow for generating sequencing libraries from viral RNA via cDNA.
Rapid RNA Viral Kit ONT (SQK-RPV001.3) Fast, single-tube library prep (< 90 mins) for RNA virus detection.
Rapid Barcoding Kit 96 ONT (SQK-RBK110.96) High-plex sample multiplexing for efficient outbreak sequencing and surveillance.
Direct RNA Sequencing Kit ONT (SQK-RNA004) Library prep for sequencing native RNA molecules to detect base modifications.
RNase Inhibitor, Murine NEB / ThermoFisher Critical for preserving integrity of viral RNA during all enzymatic steps.
AMPure XP / ProNEX Beads Beckman Coulter / Promega SPRI-based size selection and purification of libraries and nucleic acids.
Guppy / Dorado Basecaller Oxford Nanopore Converts raw current signals to nucleotide sequences (FASTQ), including modified bases.
EPI2ME / EPI2ME Labs Oxford Nanopore Cloud & local bioinformatics platforms for real-time pathogen ID and analysis.

Within the context of a broader thesis on Oxford Nanopore Technology (ONT) for viral detection in clinical samples, selecting the appropriate sequencing platform is critical for balancing throughput, cost, and turnaround time. The MinION, GridION, and PromethION platforms form a scalable ecosystem, each suited to different points on the clinical throughput spectrum.

Platform Comparison & Quantitative Data

The following table summarizes the core specifications and performance metrics relevant to clinical viral detection studies.

Table 1: ONT Platform Specifications for Clinical Viral Detection

Feature MinION (Mk1C) GridION PromethION (P2 / P48)
Form Factor Portable, integrated compute & screen Benchtop, 5 independent flow cells Benchtop (P2); Large-scale (P48)
Max Flow Cells/Run 1 5 2 (P2) / 48 (P48)
Typical Output/Run (Viral Metagenomics) 10-30 Gb 50-150 Gb 100-300 Gb (P2) / 2-4 Tb (P48)
Optimal Sample Capacity/Run 10-50 samples (multiplexed) 50-250 samples (multiplexed) 100-1000s samples (multiplexed)
Time to First Viral Genome (Post-PCR) ~1-3 hours ~1-3 hours ~1-3 hours
Key Clinical Use Case Outbreak field deployment, rapid diagnosis Hospital/regional lab, surveillance National reference lab, large-scale surveillance, pathogen discovery

Table 2: Cost & Operational Considerations

Consideration MinION GridION PromethION
Approx. Platform Cost Low Medium High (P2 & P48)
Cost per Flow Cell ~$500 - $900 ~$500 - $900 ~$1,500 - $2,000
Cost per Gb (at max yield) Highest Medium Lowest
Best for Turnaround Time Single sample, rapid (<6 hr) Small batch, rapid (<12 hr) Large batch, high-depth (24-48 hr)

Application Notes for Clinical Viral Detection

MinION: Rapid Point-of-Care/Outbreak Response

  • Application: Direct from clinical sample (nasopharyngeal swab, serum) detection and characterization of unknown viruses or known pathogens (e.g., Influenza, SARS-CoV-2, Ebola).
  • Advantage: Ultra-rapid turnaround, portable, minimal infrastructure.
  • Protocol Highlight: Rapid Metagenomic Sequencing (6-hour protocol). Sputum/transport media is nuclease-treated, followed by reverse transcription and cDNA amplification using random primers. Libraries are prepared with the Rapid Barcoding Kit (SQK-RBK114), enabling multiplexing of 12-24 samples in a single flow cell run initiated locally on the Mk1C.

GridION: Hospital/Lab-Based Surveillance

  • Application: Routine surveillance of viral outbreaks, antimicrobial resistance gene tracking in viral vectors, intra-host viral evolution studies.
  • Advantage: Flexible throughput (1-5 flow cells), high efficiency for batch processing, integrated analysis.
  • Protocol Highlight: High-Throughput Multiplexed Amplicon Sequencing. For monitoring known virus variants, use the Midnight primer set for SARS-CoV-2 (~1200 bp amplicons) or similar tiling panels. Use the Native Barcoding Expansion Kit (EXP-NBD114/196) with the Ligation Sequencing Kit (SQK-LSK114) for high-fidelity, high-multiplex (up to 96 samples per flow cell) runs on 1-5 flow cells simultaneously.

PromethION: Large-Scale Genomic Epidemiology

  • Application: National/regional pathogen genomics, large-scale wastewater surveillance, comprehensive vironne discovery in cohort studies.
  • Advantage: Massive throughput, lowest cost per genome, enables deep sequencing for rare variants.
  • Protocol Highlight: Population-Level Wastewater Surveillance. Virus concentration from wastewater via PEG precipitation/ultracentrifugation. Direct RNA sequencing (SQK-RNA002) or cDNA sequencing from random primed amplification to capture entire vironne. Use of 12-24 barcodes on a single PromethION P2 flow cell allows parallel processing of dozens of wastewater samples, generating terabytes of data for community-level variant detection.

Detailed Experimental Protocols

Protocol 1: Rapid Viral Metagenomics from Swab Samples (MinION Focus)

Objective: Detect and identify unknown viruses in <8 hours from sample to result. Workflow:

  • Sample Prep: Mix 200μL viral transport media with 10μL Turbo DNase (2U/μL). Incubate 15 min at 25°C to remove free-floating nucleic acids.
  • Nucleic Acid Extraction: Use QIAamp Viral RNA Mini Kit (Qiagen). Elute in 60μL AVE buffer.
  • Reverse Transcription & Amplification: Use SuperScript IV First-Strand Synthesis (random hexamers), followed by KAPA HiFi HotStart ReadyMix for limited-cycle (15-20) PCR.
  • Library Prep (Rapid Barcoding): Use Rapid Barcoding Kit (SQK-RBK114). Dilute 100ng amplified cDNA, tag with barcode (5 min), pool barcodes, and ligate rapid adapter (5 min). Load onto primed MinION R10.4.1 flow cell.
  • Sequencing & Analysis: Run for 1-6 hours via MinKNOW. Real-time basecalling and streaming analysis with EPI2ME for taxonomic classification (using "What's in my pot?" or FASTQ WIMP workflow).

Protocol 2: High-Fidelity Variant Calling Using Amplicons (GridION Focus)

Objective: Achieve >99.9% accuracy for single nucleotide variant (SNV) calling in viral populations. Workflow:

  • High-Fidelity PCR: Design tiling amplicons (e.g., 1200bp overlapping). Use Q5 Hot Start High-Fidelity DNA Polymerase (NEB) for minimal errors.
  • Purification: Clean amplicons with AMPure XP beads (0.6x ratio).
  • Library Prep (Ligation Sequencing): Use Native Barcoding Kit 96 (EXP-NBD196). End-repair/dA-tail 100ng DNA per sample (NEB Next Ultra II). Ligate unique barcodes to each sample. Pool equimolar amounts of barcoded samples. Ligate sequencing adapter (SQK-LSK114) to pooled library.
  • Sequencing: Load 50-100fmol library onto a primed R10.4.1 flow cell on GridION. Run for up to 72h.
  • Analysis: Basecall with super-accuracy mode (dorado). Align to reference (minimap2). Call variants using Clair3 or Medaka for consensus-level accuracy >Q50.

Diagrams

The Scientist's Toolkit: Research Reagent Solutions

Table 3: Essential Reagents for ONT-Based Viral Detection

Reagent / Kit Supplier Function in Viral Workflow
QIAamp Viral RNA Mini Kit Qiagen Extracts viral RNA/DNA from diverse clinical matrices (swabs, serum, CSF).
Turbo DNase Thermo Fisher Degrades unprotected DNA/RNA, enriching for encapsidated viral nucleic acids.
SuperScript IV Reverse Transcriptase Thermo Fisher High-temperature, highly processive RT for full-length viral cDNA synthesis.
KAPA HiFi HotStart ReadyMix Roche High-fidelity PCR for limited-cycle whole-genome amplification with low error rate.
Rapid Barcoding Kit (SQK-RBK114) Oxford Nanopore Ultra-fast library prep (<15 min) for multiplexed, rapid-turnaround metagenomics.
Native Barcoding Expansion 96 (EXP-NBD196) Oxford Nanopore Allows high-plex sample multiplexing (up to 96) for cost-effective surveillance runs.
Ligation Sequencing Kit (SQK-LSK114) Oxford Nanopore Gold-standard library prep for maximum yield and accuracy, used with barcoding kits.
AMPure XP Beads Beckman Coulter Solid-phase reversible immobilization (SPRI) for DNA purification and size selection.
NEBNext Ultra II End Repair/dA-Tailing Module New England Biolabs Prepares DNA ends for barcode and sequencing adapter ligation in native barcoding.
Flow Cells (R10.4.1) Oxford Nanopore Latest pore version providing high raw accuracy (>99%) for variant calling.

From Sample to Report: A Step-by-Step ONT Viral Detection Workflow

Within the context of Oxford Nanopore Technology (ONT) viral detection research, the integrity of downstream sequencing data is fundamentally determined by the initial nucleic acid extraction step. This application note details critical considerations and protocols for extracting DNA and RNA from blood, swabs, and tissue samples, emphasizing parameters that impact ONT sequencing success, such as fragment length, purity, and inhibitor removal.

Sample-Specific Considerations & Comparative Data

Table 1: Clinical Sample Characteristics and Extraction Challenges

Sample Type Primary Target(s) Key Challenges Recommended Extraction Kit Type Ideal Yield Range (Total Nucleic Acid) Critical QC Metric for ONT
Whole Blood Viral RNA/DNA, Host DNA PCR inhibitors (heme, immunoglobulins), high host background, RNA degradation. Column-based or magnetic bead kits with robust inhibitor removal. 0.5 - 2 µg/mL blood A260/A280: 1.8-2.0; A260/A230 > 2.0
Swabs (Nasal/Oropharyngeal) Viral RNA/DNA Low viral load, mucins, bacterial contamination, variable sample volume. Kits optimized for low elution volume (≤50 µL) and mucolysis. Highly variable (pg - ng) RT-qPCR Ct value; DV200 for RNA
Fresh/Frozen Tissue Viral DNA/RNA, Host Transcriptome Tissue homogenization, nucleases, high fat/content. Phenol-chloroform or robust silica-membrane kits. 1 - 4 µg/mg tissue DNA/RNA Integrity Number (DIN/RIN > 7)

Table 2: Impact of Sample Storage on ONT Sequencing Read Length (N50)

Sample Type Storage Condition Max Recommended Duration Observed Effect on ONT N50 Read Length
Blood (cfDNA/RNA) 4°C 24 hours Severe reduction (>50% loss) after 6h if not stabilized.
Blood (with Stabilizer) Room Temp 7 days <20% reduction when using PAXgene or similar.
Viral Swabs in VTM 4°C 72 hours Gradual reduction; rapid decline after 5 days.
Tissue (snap-frozen) -80°C Long-term Minimal degradation if thawed correctly.

Detailed Extraction Protocols

Protocol 2.1: Integrated DNA/RNA Extraction from Viral Transport Medium (VTM) Swabs for ONT Metagenomic Sequencing

Objective: Co-extract high-quality DNA and RNA from swab samples for simultaneous detection of DNA and RNA viruses via ONT.

Materials & Reagents:

  • Sample: 200 µL VTM from nasopharyngeal swab.
  • Research Reagent Solutions:
    • Proteinase K: Degrades nucleases and structural proteins.
    • Lysis/Binding Buffer (Guanidine Thiocyanate): Denatures proteins, inactivates RNases, and provides high-salt binding conditions.
    • Magnetic Beads (Silica-coated): Bind nucleic acids under high salt conditions.
    • Wash Buffers (Ethanol-based): Remove salts, proteins, and other contaminants while retaining nucleic acids on beads.
    • DNase I (RNase-free): For on-column DNA digestion during RNA-specific extraction.
    • RNase A: For on-column RNA digestion during DNA-specific extraction.
    • Nuclease-free Elution Buffer (10 mM Tris-HCl, pH 8.5): Low-salt buffer optimal for downstream ONT library prep.

Methodology:

  • Lysis: Add 200 µL VTM to 300 µL lysis/binding buffer and 20 µL Proteinase K. Vortex vigorously. Incubate at 56°C for 15 min.
  • Binding: Add 50 µL magnetic beads and 300 µL isopropanol. Mix thoroughly. Incubate at room temp for 10 min. Pellet beads on a magnet, discard supernatant.
  • Washing: Wash beads twice with 500 µL wash buffer. Perform a final wash with 80% ethanol. Air-dry beads for 5 min.
  • Elution: Elute nucleic acids in 25 µL nuclease-free elution buffer pre-heated to 65°C.
  • Optional Separation: For RNA-only workflows, add DNase I (15 min, RT) to beads after washing, followed by a final wash before elution.

Protocol 2.2: High-Molecular-Weight (HMW) DNA Extraction from Frozen Tissue for Viral Integration Site Analysis

Objective: Obtain ultra-long DNA fragments (>50 kbp) suitable for ONT long-read sequencing.

Methodology:

  • Homogenization: Under liquid nitrogen, pulverize 25 mg tissue using a mortar and pestle. Transfer powder to a tube with 1 mL lysis buffer (with Proteinase K and RNase A). Mix by inversion.
  • Gentle Lysis: Incubate at 50°C for 16 hours (overnight) with gentle agitation. Avoid vortexing.
  • Precipitation: Add 1 mL phenol:chloroform:isoamyl alcohol (25:24:1). Mix gently by inversion for 10 min. Centrifuge at 12,000 x g for 15 min at 4°C.
  • Recovery: Carefully transfer the upper aqueous phase to a new tube. Add 1 mL 100% isopropanol and mix by slow inversion. A stringy HMW DNA precipitate should form.
  • Wash: Spool DNA onto a sealed Pasteur pipette or hook. Rinse the DNA in 70% ethanol for 30 seconds.
  • Rehydration: Air-dry briefly (1-2 min) and rehydrate in 100 µL elution buffer at 4°C for 24-48 hours with gentle shaking.

Workflow and Pathway Visualizations

Title: Clinical Sample to ONT Library Workflow

Title: Inhibitor Removal in Nucleic Acid Binding

Application Notes

In the context of Oxford Nanopore Technology (ONT) viral detection from clinical samples, the selection of library preparation methodology is critical for sensitivity, turnaround time, and cost. This analysis focuses on comparing ligation-based and rapid (transposase-based) kits, integrated with target enrichment strategies suitable for viral genomics and diagnostics.

Ligation-based kits (e.g., SQK-LSK109/LSK114) offer high sequencing accuracy and are ideal for generating complete, high-quality genomes, which is paramount for identifying viral variants and transmission chains. Rapid kits (e.g., SQK-RBK004/SQK-RBK114) enable workflow completion in under 2 hours, crucial for time-sensitive clinical diagnostics. For low viral titer clinical samples, target enrichment—via amplicon-based (e.g., ARTIC network protocol) or probe-based hybridization capture—is essential to achieve sufficient coverage for reliable detection and variant calling.

Table 1: Comparison of ONT Library Prep Kits for Viral Sequencing

Feature Ligation Kit (LSK114) Rapid Kit (RBK114)
Typical Hands-on Time 75-90 minutes 10-15 minutes
Total Prep Time ~2.5 hours ~1.5 hours
DNA Input (recommended) 400-1000 ng (gDNA) 50-400 ng (gDNA)
PCR Requirement Optional (PCR-cDNA) Often recommended
Best Application De novo assembly, variant analysis, high accuracy Rapid detection, surveillance, low-complexity samples
Relative Cost per Sample High Medium

Table 2: Target Enrichment Strategies for Viral ONT Sequencing

Strategy Method Pros Cons Time Added
Amplicon-based Multiplex PCR (e.g., ARTIC v4/v5) High on-target rate (>95%), sensitive for low titer, cost-effective PCR bias, limited to known sequences, amplicon dropout 3-4 hours
Probe Capture Hybridization (e.g., Twist Pan-viral panel) Broad detection, captures novel strains, reduces PCR bias Higher cost, more complex workflow, lower on-target % 24-48 hours
No Enrichment Direct cDNA/DNA sequencing Unbiased, detects unknown agents, simple Requires high viral load, high host background 0 hours

Experimental Protocols

Protocol 1: Rapid Library Prep with Native Barcoding for Viral Detection

Objective: Prepare 12 viral RNA/cDNA samples for multiplexed ONT sequencing within 3 hours. Materials: SQK-RBK114.24 kit, NEBNext Ultra II FS DNA Module, Agencourt AMPure XP beads. Steps:

  • Reverse Transcription & cDNA Amplification (If starting from RNA): Generate cDNA using LunaScript RT SuperMix Kit. Amplify using Q5 Hot Start HiFi PCR Master Mix with viral-specific or multiplexed primers (e.g., ARTIC primer pools).
  • DNA Repair & End-Prep: Combine up to 400 ng of pooled amplicons or viral DNA with 3.5 µL NEBNext Ultra II FS Buffer and 2 µL NEBNext Ultra II FS Enzyme Mix. Incubate at 20°C for 5 minutes, then 65°C for 5 minutes.
  • Native Barcoding Ligation: To each DNA sample, add 5 µL of Rapid Barcode (from RBK114) and 20 µL of Rapid T4 DNA Ligase. Mix and incubate at room temperature (20-25°C) for 15 minutes.
  • Barcoded Sample Pooling: Combine all 12 barcoded reactions into a single 1.5 mL Eppendorf tube.
  • Adapter Ligation: Add 20 µL of Rapid Adapter (RAP) to the pooled sample. Mix and incubate at room temperature for 15 minutes.
  • Clean-up: Add 40 µL of AMPure XP beads to the adapter-ligated DNA. Follow standard bead washing protocol (80% ethanol). Elute in 15 µL Elution Buffer.
  • Load and Sequence: Quantify with Qubit, load 100-200 fmol onto a fresh R9.4.1 or R10.4.1 flow cell.

Protocol 2: Ligation-based Full-Length Viral Genome Sequencing

Objective: Generate high-accuracy, complete viral genomes from cell-free DNA or enriched samples. Materials: SQK-LSK114 kit, NEBNext Companion Module, AMPure XP beads. Steps:

  • DNA Repair & End-Prep: Combine 1 µg of input DNA (viral-enriched) with 3.5 µL Ultra II End-prep reaction buffer and 3 µL Ultra II End-prep enzyme mix. Incubate at 20°C for 5 minutes, then 65°C for 5 minutes.
  • Clean-up (1): Use 1X volumes of AMPure XP beads. Elute in 61 µL nuclease-free water.
  • Adapter Ligation: To the eluate, add 25 µL Ligation Buffer (LNB), 10 µL T4 DNA Ligase, and 5 µL Adapter Mix (AMX). Mix thoroughly and incubate at room temperature for 20 minutes.
  • Clean-up (2): Add 40 µL of AMPure XP beads to the ligation mix. Perform bead wash. Elute in 15 µL Elution Buffer (ELB).
  • Priming and Loading: Mix 12.5 µL Sequencing Buffer (SQB) and 7.5 µL Loading Beads (LB) with the eluted library. Load the entire volume onto a primed flow cell via the SpotON port.

Visualization

Title: Ligation vs Rapid Library Prep Workflow Comparison

Title: Decision Tree for Viral Target Enrichment Strategy

The Scientist's Toolkit

Table 3: Key Research Reagent Solutions for ONT Viral Sequencing

Item Function in Viral ONT Research Example Product
Reverse Transcriptase Converts viral RNA to cDNA for sequencing. LunaScript RT SuperMix Kit
High-Fidelity DNA Polymerase Amplifies viral cDNA/DNA with minimal errors for amplicon-based enrichment. Q5 Hot Start HiFi Master Mix
Magnetic Beads (SPRI) Size selection and clean-up of DNA fragments during library prep. Agencourt AMPure XP Beads
DNA Repair & End-Prep Mix Creates blunt-ended, 5'-phosphorylated DNA for ligation-based kits. NEBNext Ultra II FS Module
Native Barcodes Allows multiplexing of samples by ligating unique oligonucleotide sequences. EXP-NBD104/114 (ONT)
Flow Cell Priming Kit Prepares the nanopore array for library loading. Flow Cell Priming Kit (ONT)
Viral Enrichment Probes Biotinylated RNA probes for hybrid capture of viral sequences from host background. Twist Pan-viral Panel
Multiplex PCR Primer Pools Tiled primer sets for amplifying entire viral genomes from clinical samples. ARTIC Network nCoV-2019 V4.1

Within the broader thesis on Oxford Nanopore Technology (ONT) for viral detection in clinical samples, robust and reproducible sequencing run setup is paramount. The quality of data generated for pathogen identification, genome assembly, and variant calling is directly contingent on precise flow cell priming, sample loading, and software configuration. This protocol details the critical pre-sequencing steps, framed within a clinical virology research workflow aimed at generating high-yield, actionable data from complex clinical matrices.

Key Research Reagent Solutions

Item Function in ONT Viral Sequencing
Flow Cell (R9.4.1 or R10.4.1) The consumable containing nanopores. Choice impacts read accuracy (Q20+ vs. Q20) and homopolymer resolution.
Flow Cell Tether Connects the sequencing adapter-ligated DNA/RNA to the motor protein, enabling strand translocation through the pore.
Loading Beads (LB) Provides a viscous environment for precise sample loading and reduces diffusion within the flow cell.
Screw Cap Tubes & Wide-Bore Tips Prevent shearing of long genomic fragments or viral amplicons during handling.
Nuclease-Free Water Used for flow cell priming and dilutions; essential for preventing RNase/DNase degradation.
FLT (Flow Cell Flush Tether) / FLB (Flush Buffer) For flow cell cleaning and recovery post-run, a critical practice for cost-effective clinical research.
DNA/RNA CS (Control Sample) Standardized control used to verify flow cell and sequencing kit performance before loading precious clinical samples.

Detailed Protocols

Protocol 1: Flow Cell Priming and Equilibration

This step prepares the nanopores for sample loading by wetting and removing air bubbles.

  • Thaw Reagents: Thaw the Flush Tether (FLT), Flush Buffer (FLB), and Loading Beads (LB) at room temperature (15–25°C). Vortex and spin down.
  • Prepare Priming Mix: In a new 1.5 mL Eppendorf tube, mix:
    • 1170 µL of Flush Buffer (FLB)
    • 30 µL of Flush Tether (FLT)
    • 800 µL of Nuclease-Free Water
    • Total: 2000 µL
  • Open Flow Cell Ports: Slide the priming port cover open on the MinION/GridION/PromethION flow cell.
  • Inject Priming Mix: Using a P1000 pipette with a clean tip, draw up 800 µL of the priming mix. Slowly inject 200-400 µL into the flow cell via the priming port (avoid introducing air bubbles). Wait for 5 minutes to allow the buffer to wet the membrane.
  • Complete Priming: Slowly inject the remaining priming mix (total 800 µL delivered). A small droplet should form at the waste port.
  • Close Ports: Using a clean Kimwipe, absorb the droplet from the waste port. Close both priming and waste port covers securely.

Protocol 2: Sample Loading for Viral Enrichment Libraries

This protocol assumes a final sequencing library (e.g., from a PCR tiling amplicon or cDNA library prep) is ready.

  • Prepare Library Mix: In a new 1.5 mL Eppendorf tube, combine:
    • 75 µL of Nuclease-Free Water
    • 25 µL of 5x Running Buffer with Fuel (e.g., from SQK-LSK114 kit)
    • 12.5 µL of Loading Beads (LB)
    • 37.5 µL of final prepared library
    • Total: 150 µL
    • Mix thoroughly by pipetting slowly 10-15 times.
  • Load Sample to Flow Cell: Open the spot-on sample port cover. Pipette 150 µL of the library mix dropwise onto the port, ensuring the liquid pools without spilling.
  • Close Flow Cell: Carefully replace the spot-on cover, ensuring a tight seal to prevent leakage.
  • Begin Run: Immediately proceed to start the sequencing run via the MinKNOW software.

Protocol 3: MinKNOW Software Setup for Clinical Viral Detection

MinKNOW controls the instrument, sequencing run, and initial basecalling.

  • Connect and Check: Insert the primed and loaded flow cell into the device. Open MinKNOW and ensure the flow cell is detected and reports ≥ 800 available pores.
  • Create Run Script: Click "New Experiment".
    • Select Kit: Choose the appropriate kit (e.g., SQK-LSK114 for ligation, SQK-VSK114 for viral amplicons).
    • Select Flow Cell: Choose the correct type (FLO-MIN114, FLO-PRO114, etc.).
  • Configure Run Parameters:
    • Run ID: Use a descriptive name (e.g., PatientID_Virus_Date).
    • Run Duration: For viral genomes, 1–24 hours is often sufficient.
    • Basecalling: Enable "Basecalling" and select the appropriate model (e.g., dna_r10.4.1_e8.2_400bps_sup for high accuracy). For real-time analysis, also enable "Barcoding" if used.
    • Output: Specify a destination directory with sufficient storage (>100 GB).
  • Advanced Settings (Critical for Clinical Samples):
    • Turn "Read Splitting" ON for improved basecall accuracy on long reads.
    • Set "Read Filtering" to minimum Q score of 7-10 to reduce low-quality data stream.
    • Enable "Active Channel Selection" to focus on productive pores.
  • Begin Run: Click "Start Run". Monitor pore activity and output in real-time.

Data Presentation

Table 1: Impact of Priming Accuracy on Sequencing Yield in Viral Studies

Priming Step Deviation Median Pores Available Post-Priming Approximate Yield Loss (%) Impact on Viral Genome Coverage
Protocol followed precisely 1200–1400 0% Optimal, complete genome coverage likely.
Air bubble introduced 800–1000 ~30% Risk of incomplete genome assembly.
Incorrect buffer volume 600–800 ~50% Severe coverage drop, may miss key variants.
No priming wait step 900–1100 ~20% Reduced consistency, increased pore failure rate.

Table 2: Recommended MinKNOW Settings for Viral Detection Scenarios

Clinical Sample Type Recommended MinKNOW Basecalling Model Minimum Run Time Target Output Key Rationale
Viral Metagenomics (direct RNA) rna_r10.4.1_e8.2_400bps_sup 72 hrs 10-20 Gb Maximize sensitivity for low-abundance pathogens.
SARS-CoV-2 Amplicon (ARTIC) dna_r10.4.1_e8.2_400bps_sup 6-12 hrs 1-2 Gb High accuracy for variant calling.
Influenza Whole Genome dna_r9.4.1_e8.1_sup 24 hrs 5 Gb Balance of accuracy and yield for segmented genome.

Visualizations

ONT Viral Detection Sequencing Workflow

Flow Cell Priming Step-by-Step Protocol

MinKNOW Software Configuration Logic

This document provides Application Notes and Protocols for the implementation of key bioinformatics pipelines within Oxford Nanopore Technology (ONT) based research for viral detection in clinical samples. The workflows described herein are integral to a broader thesis focused on leveraging long-read, real-time sequencing for pathogen characterization, outbreak surveillance, and therapeutic development. The transition from research to potential clinical application necessitates robust, reproducible, and accessible analytical pathways.

The selection of an analysis pipeline depends on the balance between ease-of-use, computational resource requirements, customization needs, and the specific viral target.

Table 1: Comparative Summary of Viral Detection Pipelines for ONT Data

Feature EPI2ME / What's In My Pot (WIMP) ARTIC Network Workflow Custom (e.g., Nextflow) Workflow
Primary Use Case Real-time taxonomic classification (species-level). Targeted amplification & highly accurate consensus genome generation. Flexible, end-to-end analysis from raw data to complex outputs.
Ease of Use Very High (cloud-based, point-and-click). Moderate (requires command-line & environment setup). Low (requires significant bioinformatics expertise).
Speed Fast (near real-time). Moderate (batch-based, ~hours). Variable (depends on workflow design and scale).
Customization Very Low (fixed parameters). Moderate (primer schemes, some adjustable parameters). Very High (fully customizable at every step).
Key Output Abundance report, identification of major constituents. High-quality consensus sequence (FASTA), variant calls (VCF). Multi-sample reports, phylogenies, annotated variants, custom QC metrics.
Typical Throughput Single to tens of samples. Tens to hundreds of samples (scalable). Scalable from single samples to population-level studies.
Best For Rapid pathogen identification in metagenomic samples. Specific virus genomic surveillance (e.g., SARS-CoV-2, Ebola, Influenza). Novel virus discovery, integrated multi-omics, or method development.

Detailed Experimental Protocols

Protocol: Viral Metagenomic Detection using EPI2ME WIMP

Objective: To rapidly identify viral sequences in a clinical sample (e.g., nasopharyngeal swab) using ONT sequencing and the cloud-based EPI2ME platform. Sample Input: Barcoded, adapter-ligated cDNA or DNA library prepared from extracted total nucleic acids.

Procedure:

  • Sequencing: Load the prepared library onto a MinION, GridION, or PromethION flow cell. Begin the sequencing run via MinKNOW software.
  • Real-Time Analysis Configuration: Within MinKNOW, enable the "EPI2ME" agent for "What's In My Pot (WIMP)".
  • Data Streaming: As basecalling occurs, FASTQ reads are automatically streamed to the EPI2ME cloud server.
  • Classification: Each read is taxonomically classified in near real-time by comparison against curated reference databases (e.g., NCBI RefSeq).
  • Result Visualization: Access the results via the EPI2ME website. The interactive dashboard displays:
    • A running summary of classified reads.
    • A taxonomic tree view of detected organisms.
    • A time-plot showing read classification over the course of the run.
  • Interpretation: Identify the dominant viral species based on read counts. Cross-reference with control samples to distinguish contamination from true infection.

Protocol: Targeted Genome Sequencing using the ARTIC Workflow

Objective: To generate a high-coverage, high-accuracy consensus genome sequence of a specific virus (e.g., SARS-CoV-2) from amplicon-based ONT sequencing.

Procedure:

  • Wet-Lab: Perform cDNA synthesis and tiled multiplex PCR using the appropriate ARTIC Network primer scheme (e.g., V4.1 for SARS-CoV-2).
  • Library Preparation: Prepare the sequencing library using the Ligation Sequencing Kit (SQK-LSK109/110), incorporating barcodes if multiplexing.
  • Basecalling & Demultiplexing: Run guppy_basecaller (high-accuracy mode recommended) with the --barcode_kits option if applicable.

  • Read Filtering (Optional): Use filtlong or similar to remove very short/low-quality reads.

  • Genome Assembly with artic pipeline: Use the artic toolkit's minion command.

  • Output: The primary outputs are: <sample_name>.consensus.fasta (the consensus genome) and <sample_name>.pass.vcf.gz (identified variants relative to the reference).

Protocol: Implementing a Custom Nextflow Workflow for Viral Analysis

Objective: To create a reproducible, scalable pipeline for comprehensive viral analysis, integrating quality control, alignment, variant calling, and phylogenetics.

Procedure:

  • Workflow Design: Define pipeline stages: QC (NanoPlot, FastQC), alignment (minimap2), primer trimming (iVar), consensus generation (bcftools), lineage assignment (Pangolin), and phylogeny (Nextstrain).
  • Containerization: Use Docker or Singularity containers for each tool to ensure reproducibility.
  • Nextflow Script Development: Write the main.nf script, defining processes, channels, and workflow logic.

  • Configuration: Set up nextflow.config to specify compute resources (e.g., SLURM, AWS), container engine, and default parameters.
  • Execution: Run the pipeline, specifying the input directory of FASTQ files.

  • Results Consolidation: The pipeline will generate a structured results directory containing multi-sample reports, consensus sequences, lineage reports, and phylogenetic trees.

Visualization of Workflows

Title: EPI2ME WIMP Real-Time Analysis Flow

Title: ARTIC Bioinformatic Pipeline Steps

Title: Custom Scalable Pipeline with Nextflow

The Scientist's Toolkit: Key Research Reagent Solutions

Table 2: Essential Materials and Reagents for ONT Viral Detection Workflows

Item Name Supplier / Example Function in Viral Detection Workflow
Total Nucleic Acid Extraction Kit QIAamp Viral RNA Mini Kit, MagMAX Viral/Pathogen Kit Isolates viral RNA/DNA from diverse clinical sample matrices (swab, serum, tissue).
Reverse Transcription & PCR Kits LunaScript RT SuperMix, Q5 Hot Start High-Fidelity 2X Master Mix Generates cDNA and amplifies viral targets with high fidelity, essential for ARTIC and amplicon workflows.
ARTIC Primers ARTIC Network (public designs), Midnight primers Tiled primer sets for specific viruses to generate short, overlapping amplicons for complete genome coverage.
ONT Ligation Sequencing Kit SQK-LSK109 or SQK-LSK110 Prepares cDNA/DNA amplicons for sequencing by adding ONT-specific adapters.
ONT Flow Cell R9.4.1 (FLO-MIN106) or R10.4.1 (FLO-MIN114) The consumable containing nanopores for sequencing. R10.4.1 offers improved accuracy for homopolymer regions.
Native Barcoding Expansion Kit EXP-NBD104/114/196 Allows multiplexing of multiple samples on a single flow cell, increasing throughput and reducing cost per sample.
Positive Control RNA SARS-CoV-2 RNA Twist Synthetic Control Validates the entire wet-lab and dry-lab workflow, from extraction to sequencing and analysis.
Reference Genome Sequences NCBI GenBank, GISAID Essential for alignment, consensus generation, and variant calling. Must be kept up-to-date.

Overcoming Challenges: Maximizing Accuracy and Yield in Viral Sequencing

Within the context of Oxford Nanopore Technology (ONT) for viral detection in clinical samples, the integrity of the sequencing library is paramount. Common issues such as low DNA yield, a high proportion of short reads, and the presence of adapter dimer can severely compromise data quality, leading to reduced sensitivity and unreliable clinical results. This document provides application notes and detailed protocols to identify, troubleshoot, and resolve these critical challenges.

Table 1: Impact of Common Library Preparation Issues on ONT Sequencing Metrics for Viral Detection

Issue Typical Metric Impact Clinical Consequence
Low Yield Total library yield < 50 fmol; pores occupied < 30% Insufficient coverage for low-titer viruses; increased risk of false negatives.
Short Reads N50 < 5 kb; >40% of reads < 1 kb Poor genome assembly; reduced ability to detect structural variants or mixed infections.
Adapter Dimer >15% of pores occupied by < 200 bp events Wasted sequencing capacity; reduced throughput for target sequences.

Table 2: Recommended QC Thresholds for Viral ONT Libraries

QC Method Optimal Range Failure Indicator
Qubit dsDNA HS Assay ≥ 50 fmol total library < 20 fmol
Fragment Analyzer/TapeStation Peak size distribution matching expectation (e.g., ~400-700 bp for cDNA) Major peak at ~100-200 bp (adapter dimer)
Qubit/Quantus Fluorometer Ratio > 0.8 < 0.5 (suggests significant ssDNA or adapter dimer)

Detailed Experimental Protocols

Protocol 3.1: Diagnosis and Remediation of Low Yield from Viral Clinical RNA

Objective: To increase cDNA/DNA yield from low-input, degraded clinical samples (e.g., nasopharyngeal swabs).

Reagents: See "The Scientist's Toolkit" (Section 5). Workflow:

  • Input Enhancement:
    • Perform dual-priming for cDNA synthesis using both random hexamers and sequence-specific primers targeting the virus of interest.
    • Add carrier RNA (e.g., 1 µg/ml poly-A RNA) during RNA extraction to improve recovery.
    • Use a post-extraction RNA cleanup step with a high-efficiency bead-based system (2:1 bead:sample ratio).
  • Amplification Optimization:

    • For PCR-based library prep (e.g., Ligation Sequencing Kit V14), increase PCR cycle number by 2-4 cycles incrementally. Do not exceed 18 cycles to avoid skew.
    • Use a robust, high-fidelity PCR master mix designed for complex templates.
    • Perform multiple parallel amplification reactions and pool them before cleanup.
  • Purification Recovery:

    • Elute DNA in 15-25 µL of warm (37°C) nuclease-free water or EB buffer from columns.
    • For bead-based cleanup, let the eluate sit on the beads for 5 minutes before magnetic separation.
    • Use a lower bead-to-sample ratio (e.g., 0.6:1) for the final size selection to minimize loss of smaller viral fragments.

Protocol 3.2: Reduction of Adapter Dimer Formation

Objective: To minimize the ligation of sequencing adapters to each other instead of to target DNA.

Workflow:

  • Input DNA Preparation:
    • Perform stringent double-sided size selection using SPRI beads. First, remove large fragments with a 0.4x bead ratio. Keep supernatant. Then, recover target fragments from the supernatant with a 0.8x bead ratio to the original sample volume. Discard this final supernatant, which contains adapter dimer.
    • Quantify the size-selected DNA using a fluorometer. Proceed only if yield is sufficient.
  • Adapter Ligation Optimization:

    • Dilute the NEBNext Quick T4 DNA Ligase buffer 1:1 with nuclease-free water immediately before use to reduce PEG concentration, which can promote dimerization.
    • Reduce the volume of sequencing adapter in the ligation reaction by 25-50%. Use the Ligation Sequencing Kit's "high input" protocol if yield allows.
    • Perform ligation at room temperature (20-22°C) for exactly 10 minutes, then place immediately on ice.
  • Post-Ligation Cleanup:

    • Use AMPure XP beads at a 0.4x ratio to the ligation reaction volume. This will preferentially bind fragments >~300 bp, removing most adapter dimer (~120-140 bp).
    • Wash beads twice with freshly prepared 70% ethanol.
    • Elute in a minimal volume (e.g., 12 µL) to maximize concentration.

Protocol 3.3: Protocol for Generating Long Reads from Viral Amplicons

Objective: To convert short, multiplexed viral amplicons (e.g., from tiled PCR) into concatenated long molecules suitable for ONT sequencing.

Workflow:

  • Amplicon Generation: Perform a multiplexed PCR using tiled, overlapping primer pools designed for the target viral genome (e.g., ~400 bp amplicons with 50 bp overlap).
  • Purification: Clean up PCR products with a 1x SPRI bead ratio.
  • End-Repair & A-tailing: Use the NEBNext Ultra II End Repair/dA-tailing Module according to the standard protocol.
  • Ligation without Fragmentation: Use the NEB Blunt/TA Ligase Master Mix to ligate the amplicons together at their blunt/A-tailed ends. Use a high DNA concentration (≥ 50 ng/µL) and ligate for 1 hour at room temperature to promote concatemer formation.
  • Size Selection: Perform a 0.2x SPRI bead cleanup. Keep the supernatant (containing long concatemers). To this supernatant, add beads at a 0.8x ratio to the original sample volume to recover the long fragments. Elute.
  • Library Construction: Proceed with standard ONT adapter ligation (Protocol 3.2) on the size-selected concatemers.

Visualization of Workflows and Relationships

Title: Protocol for Overcoming Low Yield

Title: Adapter Dimer Reduction Strategy

Title: Generating Long Reads from Amplicons

The Scientist's Toolkit: Key Research Reagent Solutions

Table 3: Essential Reagents for Troubleshooting ONT Viral Libraries

Item Function in Protocol Key Consideration for Viral Samples
Poly-A Carrier RNA Improves recovery of low-concentration viral RNA during extraction/isopropanol precipitation. Use RNase-free, and ensure it does not interfere with downstream viral-specific primers.
SuperScript IV Reverse Transcriptase High-efficiency cDNA synthesis from often degraded clinical RNA. Use with a mix of random hexamers and specific primers for robustness.
AMPure XP / SPRIselect Beads Size selection and cleanup. Critical for adapter dimer removal. Ratios are crucial. Precisely calibrate for target fragment retention.
NEBNext Ultra II End Repair/dA-Tailing Module Prepares fragment ends for adapter ligation. Essential for concatemerization protocol (Protocol 3.3).
NEB Blunt/TA Ligase Master Mix Ligates blunt-end/A-tailed amplicons into concatemers. High DNA concentration is required for efficient concatemer formation.
Qubit dsDNA HS Assay / Quantus Fluorometer Accurate quantification of low-yield libraries. Preferable to spectrophotometry for specificity and sensitivity.
Agilent Fragment Analyzer / TapeStation Qualitative assessment of library size profile and dimer detection. The D5000/HST assay is ideal for viewing the 100-200 bp dimer peak.

Within the broader thesis on Oxford Nanopore Technology (ONT) for viral detection in clinical samples, a central challenge is the accurate identification of viral sequences from samples with low viral loads and high host nucleic acid background. This is critical for early infection diagnosis, monitoring treatment efficacy, and viral variant surveillance. This application note details protocols and strategies to optimize input material for ONT sequencing to overcome these limitations.

The primary obstacles in low viral load sample sequencing are summarized in the table below.

Table 1: Key Challenges in Low Viral Load Viral Metagenomics

Challenge Typical Metric/Value Impact on ONT Sequencing
Low Viral Nucleic Acid < 1000 copies/µL in extracted RNA/DNA Insufficient material for library prep; stochastic sampling errors.
High Host Background Human DNA/RNA constitutes >99.99% of total nucleic acids. Viral reads are "lost"; increased sequencing cost per viral read.
Sequencing Depth Requirement Often >5-10M reads/sample for reliable detection. Increased flow cell consumption and cost.
RNA/DNA Co-extraction Efficiency Variable recovery (10-80%) based on method. Impacts absolute viral copy number input.
PCR Amplification Bias Up to 1000-fold variation in amplicon representation. Skews viral genome coverage and variant calling.

Experimental Protocols

Protocol 3.1: Probe-based Hybridization Capture for Viral Enrichment

This protocol enriches viral sequences from complementary DNA (cDNA) or DNA libraries prior to ONT sequencing.

Materials:

  • Biotinylated DNA Probes: Pan-viral family probes (e.g., ViroCap, Twist Pan-Viral Panel).
  • Magnetic Streptavidin Beads (e.g., Dynabeads MyOne Streptavidin C1).
  • Hybridization Buffer (e.g., SSC, formamide, EDTA, SDS).
  • Wash Buffers: Low-stringency and high-stringency (SSPE, SDS).
  • Nuclease-free Water and Elution Buffer (10mM Tris-HCl, pH 8.0).

Method:

  • Library Preparation: Generate ONT sequencing library from total nucleic acids using kits like the SQK-PBK004 or SQK-RBK114. Do not add sequencing adapters.
  • Denaturation & Hybridization: Mix 100-500 ng of prepared library with 1-2 µg of biotinylated probes in hybridization buffer. Denature at 95°C for 5 min, then incubate at 65°C for 16-24 hours with agitation.
  • Capture: Pre-wash streptavidin beads. Add beads to the hybridization mix and incubate at room temperature for 45 min with rotation.
  • Washing: Capture beads on a magnet. Perform sequential washes: twice with low-stringency buffer (room temperature), once with high-stringency buffer (65°C).
  • Elution: Resuspend beads in nuclease-free water or elution buffer. Heat at 95°C for 5 min to elute the captured library. Immediately place on magnet and transfer supernatant.
  • Adapter Ligation & Sequencing: Add ONT sequencing adapters (from the kit used in step 1) to the enriched library. Proceed with standard priming and loading on a MinION or PromethION flow cell.

Protocol 3.2: Targeted Amplicon Sequencing for Low Viral Load Samples

This protocol uses PCR to amplify specific viral regions, ideal for known viruses at extremely low copy numbers.

Materials:

  • Multiplex PCR Primers: Designed for tiling amplicons across target viral genomes (e.g., ARTIC Network primers for SARS-CoV-2).
  • High-Fidelity, Long-Amp PCR Master Mix (e.g., Q5 Hot Start, LongAmp Taq).
  • PCR Clean-up Beads (e.g., AMPure XP).
  • ONT Native Barcoding Expansion Kit (EXP-NBD104/114/196).

Method:

  • Reverse Transcription & cDNA Synthesis: For RNA viruses, perform first-strand cDNA synthesis using random hexamers and a reverse transcriptase with high processivity.
  • Multiplex PCR: Set up two separate, overlapping multiplex PCR reactions (Pools A & B) per sample to minimize primer interference. Use a touch-down thermocycling protocol.
  • Pooling & Clean-up: Combine Pools A and B. Purify the pooled amplicons with a 0.6x bead clean-up to remove primers and short fragments.
  • Library Preparation: Quantify amplicons. Use the native barcoding kit to barcode samples. Ligate sequencing adapters (SQK-LSK114).
  • Sequencing: Load the pooled, barcoded library onto a flow cell. Target 50-100x coverage across the viral genome.

Protocol 3.3: Host Depletion via DNase/RNase Treatment

This protocol reduces host background by selectively digesting unprotected host nucleic acids.

Materials:

  • Benzonase Nuclease: Degrades all forms of DNA and RNA.
  • RNase A: Degrades single-stranded RNA.
  • DNase I: Degrades single and double-stranded DNA.
  • Viral Lysis Buffer (with detergents and proteinase K).
  • Nuclease Inhibitors (e.g., EDTA, EGTA).

Method:

  • Sample Lysis: Lyse clinical sample (swab, plasma) in a viral transport medium containing a strong detergent and proteinase K to liberate viral capsids.
  • Nuclease Treatment: Add a combination of Benzonase (25 U/µL) and possibly RNase A (if targeting DNA viruses) or DNase I (if targeting RNA viruses) to the lysate. Incubate at 37°C for 30-60 min. Note: Viral nucleic acids inside intact capsids are protected.
  • Inactivation & Viral Lysis: Add EDTA (10mM final) to chelate Mg2+ and inactivate nucleases. Then, add a second, stronger lysis buffer to break viral capsids and release protected viral nucleic acids.
  • Nucleic Acid Extraction: Proceed with standard silica-column or magnetic bead-based extraction.
  • Proceed to Library Prep: Use the extracted, host-depleted nucleic acids for ONT library preparation.

Diagrams

The Scientist's Toolkit: Research Reagent Solutions

Table 2: Essential Reagents for Optimizing ONT Viral Detection

Reagent / Kit Supplier (Example) Primary Function in Protocol
SQK-RBK114 Kit Oxford Nanopore Combined reverse transcription, cDNA PCR, and rapid barcoding for RNA viruses.
SQK-LSK114 Ligation Kit Oxford Nanopore High-sensitivity, ligation-based library prep for DNA or double-stranded cDNA.
ViroCap Enrichment Probes Custom (e.g., IDT, Twist) Biotinylated DNA oligonucleotides to capture and enrich diverse viral sequences.
Dynabeads MyOne Streptavidin C1 Thermo Fisher Magnetic beads for immobilizing biotin-probe:target complexes during capture.
ARTIC Network Primer Pools GitHub Repository Multiplex PCR primers for tiling amplicons across specific viral genomes (e.g., SARS-CoV-2, MPXV).
Q5 Hot Start High-Fidelity Master Mix NEB High-fidelity PCR for generating accurate amplicons with minimal bias.
Benzonase Nuclease MilliporeSigma Enzymatic degradation of host nucleic acids outside of viral capsids.
AMPure XP Beads Beckman Coulter SPRI bead-based clean-up and size selection for PCR products and libraries.
RiboGuard RNase Inhibitor Lucigen Protects viral RNA during extraction and cDNA synthesis from residual RNases.

Within Oxford Nanopore Technology (ONT) viral detection research using clinical samples, basecalling accuracy is a critical determinant of downstream analytical success. Accurate identification of viral sequences, including low-abundance pathogens and critical SNPs, relies on the computational translation of raw electrical signals (squiggles) into nucleotide sequences. Researchers must strategically select a basecalling model—Fast (FAST), High-Accuracy (HAC), or Duplex—balancing accuracy, computational resource requirements, and throughput. This protocol is framed within a thesis aiming to establish a robust, clinical-grade workflow for sensitive and specific viral detection and characterization from complex human samples.

Quantitative Comparison of Basecalling Models

The following table summarizes the latest performance metrics and characteristics of the three primary basecalling model types available for ONT data, as per current community benchmarking and ONT publications. The Q-score (Phred-scaled accuracy) is the key metric.

Table 1: Comparison of ONT Basecalling Models for Viral Detection Research

Model Type Typical Read Accuracy (Q-score) Relative Speed CPU/GPU Recommendation Key Advantage Best Use Case in Viral Research
Fast (FAST) ~Q15-18 Fastest (≥ 400 samples/day/GPU) GPU (modest) Ultra-high throughput, rapid turnaround Initial rapid screening, abundance estimation, where speed is paramount
High-Accuracy (HAC) ~Q20-25 Moderate (~50 samples/day/GPU) GPU (high-memory) Optimal balance of accuracy & speed Primary model for definitive variant calling, consensus generation, genome assembly
Duplex ~Q30+ Slowest (1-5 samples/day/GPU) High-performance GPU Highest single-read accuracy Gold-standard for resolving complex regions, low-frequency variants, and ambiguous alignments

Experimental Protocols

Protocol A: Benchmarking Basecaller Models for Clinical Viral Detection

Objective: To empirically determine the optimal basecalling model for a specific viral detection study using characterized control material.

Materials:

  • ONT sequencing run data (.fast5 or .pod5) from a clinical sample spiked with a known reference virus (e.g., SARS-CoV-2, HCV control).
  • GPU-enabled server with ONT Dorado basecaller installed.
  • Reference viral genome sequence (FASTA).
  • Alignment software (minimap2).
  • QC and analysis tools (Samtools, pycoQC).

Procedure:

  • Basecalling: Basecall the same dataset (or a representative subset of reads) separately using Dorado with the fast, hac, and duplex model parameters.
    • HAC Command: dorado basecaller sup /path/to/model dna_r10.4.1_e8.2_400bps_hac@v4.3.0 /path/to/pod5 > calls_hac.bam
    • FAST Command: dorado basecaller sup /path/to/model dna_r10.4.1_e8.2_400bps_fast@v4.3.0 /path/to/pod5 > calls_fast.bam
    • Duplex Command: First, basecall in simplex mode, then identify duplex reads: dorado duplex /path/to/model dna_r10.4.1_e8.2_400bps_sup@v4.3.0 /path/to/pod5 > calls_duplex.bam
  • Alignment: Align the resulting .bam files to the reference viral genome using minimap2.
  • Accuracy Calculation: For each model's aligned file, calculate the median read Q-score mapping to the viral reference using pycoQC or custom scripts.
  • Variant Calling: Perform variant calling on each dataset. Compare the precision and recall for identifying known SNPs in the control.
  • Analysis: Create summary plots comparing accuracy, throughput, and variant detection performance across models to inform model selection for the full study.

Protocol B: Integrated Workflow for High-Confidence Viral Variant Detection

Objective: To implement a tiered basecalling strategy maximizing both efficiency and confidence in final variant calls.

Materials: As in Protocol A.

Procedure:

  • Rapid Screening: Use the FAST model on all incoming runs to quickly confirm the presence/absence of target viruses and estimate viral load from read counts.
  • Primary Analysis: Re-basecall samples of interest (e.g., positive samples) using the HAC model for all downstream consensus generation, phylogenetic analysis, and primary variant identification.
  • High-Resolution Interrogation: For samples where the HAC model yields ambiguous or low-confidence variant calls in key genomic regions (e.g., primer targets, drug resistance sites), perform Duplex basecalling on a subset of reads. Use these high-fidelity reads to resolve uncertainties.

Visualizations

Basecaller Model Selection Decision Pathway

Decision Pathway for Basecaller Model Selection

Tiered Viral Detection Analysis Workflow

Tiered Workflow for Clinical Viral Analysis

The Scientist's Toolkit: Research Reagent Solutions

Table 2: Essential Materials for ONT Viral Detection Basecalling Research

Item Function/Application in Viral Research Example/Specification
ONT Control Virus Provides a known accuracy benchmark for basecaller evaluation within a complex background. Lambda Phage DNA, HiFi Sars-CoV-2 Control (ATCC)
Dorado Basecaller The core software for translating raw signal to sequence; supports all three model types. ONT's production basecaller; requires GPU.
GPU Computing Resource Accelerates basecalling, especially for HAC and Duplex models. NVIDIA Tesla/Ampere architecture (e.g., A100, V100) with ≥16GB VRAM.
Reference Viral Genomes Essential for alignment, accuracy calculation, and variant calling. Curated databases (NCBI Virus, GISAID).
MinKNOW The instrument control software; settings here affect raw data quality for basecalling. Ensure "Basecalling" is disabled to retain raw .pod5 files.
Biological Sample The test matrix containing the target virus. Clinical samples (e.g., nasopharyngeal swab, serum).
ONT Sequencing Kit Generates the raw electrical signals for analysis. Ligation Sequencing Kit (SQK-LSK114) with R10.4.1 flow cells.
Alignment & QC Tools For processing basecalled reads and assessing performance metrics. Minimap2 (alignment), Samtools (BAM processing), pycoQC (quality metrics).

Cost and Time Optimization Strategies for Efficient Clinical Screening

The pursuit of rapid, cost-effective viral diagnostics is central to modern public health and therapeutic development. This application note, framed within a broader thesis on Oxford Nanopore Technology (ONT) for viral detection in clinical samples, details integrated strategies to optimize the two critical constraints in clinical screening: cost and time. By leveraging the real-time, long-read sequencing capabilities of ONT platforms, alongside streamlined protocols and intelligent bioinformatic pipelines, researchers can achieve significant efficiencies without compromising diagnostic accuracy. These optimizations are pivotal for scaling surveillance, accelerating drug development studies, and enabling point-of-care genomic analysis.

Table 1: Comparison of Viral Screening Methodologies for Clinical Samples

Method Average Cost per Sample (USD) Time-to-Result (Hands-on to Analysis) Throughput (Samples per Run) Key Advantage Primary Limitation
qRT-PCR (Multiplex) $15 - $40 2 - 4 hours 96 - 384 Gold standard sensitivity/speed Targeted; limited pathogen discovery
ONT Native Barcoding (24-plex) $50 - $100 6 - 10 hours 12 - 96 Real-time data, genome completeness, variant calling Higher per-sample cost than PCR
ONT Rapid Barcoding (96-plex) $30 - $60 3 - 6 hours 96 - 384 Fastest ONT workflow, lower cost Lower output per barcode, shorter reads
Metagenomic NGS (Illumina) $80 - $200 24 - 48 hours+ 24 - 96 High accuracy, high depth Longer turnaround, complex analysis
Rapid Antigen Test $5 - $15 15 - 30 minutes 1 Ultra-fast, point-of-care Lower sensitivity, qualitative only

Table 2: Cost Breakdown for an Optimized ONT Screening Workflow (96 samples)

Cost Component Approximate Cost per Sample (USD) Optimization Strategy
ONT Flow Cell (R10.4.1, reuse considered) $20 - $40 Sequential or adaptive loading; flow cell washing/refurbishment
Library Prep & Barcoding Kits $15 - $25 Use of rapid barcoding kits; multiplexing ≥ 96 samples
Extraction & QC Reagents $5 - $10 Automated extraction; direct input protocols where valid
Labor & Overhead Variable Automated pipetting; streamlined bioinformatics
Total (Optimized) $40 - $75 Highly dependent on multiplex level and flow cell reuse

Detailed Experimental Protocols

Protocol 3.1: Optimized ONT Rapid Barcoding for High-Throughput Viral RNA Detection

Objective: To detect and identify viral pathogens from clinical swab samples (e.g., VTM) with a sub-8-hour workflow.

I. Sample Preparation & Nucleic Acid Extraction

  • Input: 200 µL of viral transport medium (VTM) or clarified supernatant.
  • Extraction: Use an automated magnetic bead-based RNA/DNA extraction system (e.g., Thermo Fisher KingFisher, QIAGEN QIAcube).
  • Elution: Elute in 30-50 µL of nuclease-free water. Optimization: For direct detection, use 5 µL of raw sample with the ONT direct RNA/DNA protocol (validated per sample type).
  • QC: Quantify using a fluorescence broad-range RNA assay (e.g., Qubit RNA HS). Acceptable range: > 5 ng/µL. Proceed if below threshold, as sequencing is tolerant of low input.

II. Library Preparation (ONT Rapid Barcoding Kit SQK-RBK114.24/.96) Critical for time optimization.

  • Reverse Transcription & cDNA Synthesis (Optional but recommended for RNA viruses): Use the LunaScript RT SuperMix Kit in a 10 µL reaction.
  • Rapid Adapter Ligation:
    • Combine 7.5 µL of sample (cDNA or DNA) with 2.5 µL of Rapid Barcoding Buffer.
    • Add 5 µL of a unique Rapid Barcode from the 96-barcode set. Incubate at 30°C for 2 minutes.
    • Add 10 µL of Rapid Adapter (RAP) and 25 µL of Blunt/TA Ligase Master Mix. Incubate at room temperature for 5 minutes.
  • Pooling: Combine equal volumes (e.g., 5 µL) of each uniquely barcoded reaction into a single 1.5 mL LoBind tube.
  • Clean-up: Add 0.4x volumes of AMPure XP beads to the pool, wash twice with 70% ethanol, and elute in 15 µL of Elution Buffer.

III. Sequencing & Real-Time Analysis

  • Priming & Loading: Prime the Flongle or MinION R10.4.1 flow cell with 200-500 µL of Flow Cell Priming Kit buffer. Load the entire 15 µL library mix.
  • Sequencing: Run for up to 12 hours on MinKNOW. Time Optimization: Set the run to "Read Until" mode.
  • Real-Time Adaptive Sampling (Read Until): Use the readfish or MinKNOW's adaptive sampling feature with a pre-defined reference panel of viral genomes. Reject human host reads in real-time to enrich for viral targets, saving sequencing time and cost.

IV. Bioinformatics Pipeline (Optimized for Speed)

  • Basecalling & Demultiplexing: Use dorado (ONT's fast basecaller) in super-accuracy mode concurrently with sequencing or immediately after.
  • Alignment: Map reads to a curated viral genome database (NCBI Viral RefSeq) using minimap2 with preset -ax map-ont.
  • Consensus & Variant Calling: Use medaka for variant calling and bcftools to generate consensus sequences for positive samples.
  • Reporting: Automated script to generate a .csv report with columns: SampleID, TargetVirus, CoverageDepth, ConsensusQC_Pass (Y/N).
Protocol 3.2: Flow Cell Washing and Re-use Protocol

Objective: To significantly reduce per-sample cost by re-using a MinION R10.4.1 flow cell 2-3 times.

  • Post-Run Wash: At the end of a sequencing run, immediately inject 1 mL of freshly prepared Flow Cell Wash Kit (EXP-WSH004) solution into the flow cell via the priming port.
  • Incubation: Allow to incubate at room temperature for 15 minutes.
  • Storage: Seal the flow cell with the original cap and store at 4°C for up to one week before re-priming and re-loading.
  • QC for Re-use: Before the next run, check the number of active pores in the platform QC step in MinKNOW. A drop to < 50% of the original active pores indicates the flow cell should be retired.

Mandatory Visualizations

Diagram 1: Optimized ONT Workflow & Cost Gates

Diagram 2: Adaptive Sampling Logic

The Scientist's Toolkit: Key Research Reagent Solutions

Table 3: Essential Materials for Cost-Optimized ONT Viral Screening

Item Function in Workflow Example Product/Kit Optimization Note
Automated Extraction System High-throughput, consistent NA isolation from clinical matrices. KingFisher Flex, QIAcube Reduces hands-on time and cross-contamination risk.
ONT Rapid Barcoding Kit Fast, one-tube library prep with unique sample barcodes for multiplexing. SQK-RBK114.24 / .96 Enables 96-plex pooling in under 2 hours, critical for cost-sharing.
R10.4.1 Flow Cell High-accuracy nanopore array for sequencing. FLO-MIN114, FLO-FLG114 Higher accuracy for variant calling. Reuse is a primary cost-saving lever.
Flow Cell Wash Kit Regenerates pores for flow cell re-use. EXP-WSH004 Extends flow cell life 2-3x, directly cutting largest cost component.
Direct RNA/DNA Kit Bypasses extraction and amplification for ultra-fast input. SQK-DCS109, SQK-RNA004 For high-titer samples, saves >1 hour and extraction cost. Requires validation.
AMPure XP Beads SPRI-based clean-up and size selection of libraries. Beckman Coulter A63881 Standard for final library clean-up before loading.
Real-Time Analysis Server Local compute for basecalling and adaptive sampling. NVIDIA GPU-equipped server Enables dorado and readfish for real-time decision-making, saving time & flow cell pores.
Curated Viral Database Targeted reference for alignment and adaptive sampling. Custom NCBI Viral RefSeq subset Focuses analysis, increases speed and sensitivity for pathogens of interest.

Benchmarking Performance: How ONT Stacks Up Against NGS and PCR Methods

Within the framework of a doctoral thesis investigating Oxford Nanopore Technology (ONT) for viral detection in clinical samples, establishing benchmark performance against gold-standard quantitative PCR (qPCR) and emerging digital droplet PCR (ddPCR) is imperative. This application note details protocols and presents comparative sensitivity and specificity data from contrived clinical specimens spiked with SARS-CoV-2 RNA, evaluating ONT (amplification-based cDNA sequencing), reverse-transcription qPCR (RT-qPCR), and reverse-transcription ddPCR (RT-ddPCR). The data underscore the trade-offs between throughput, quantitative accuracy, and limit of detection (LOD) critical for assay selection in clinical research and therapeutic monitoring.

The validation of novel diagnostic platforms like ONT requires rigorous comparison to established quantitative methods. While RT-qPCR offers sensitive, high-throughput quantification, RT-ddPCR provides absolute quantification without a standard curve, excelling at low viral copy detection and tolerance to inhibitors. ONT sequencing delivers genomic context and variant identification but faces different sensitivity challenges related to library preparation and flow cell chemistry. This protocol outlines a parallel testing framework to generate comparable sensitivity (true positive rate) and specificity (true negative rate) metrics across these technologies.

Key Research Reagent Solutions

Item Function in Protocol
Heat-inactivated SARS-CoV-2 A safe, non-infectious source of viral RNA for spiking into negative clinical matrix (e.g., nasal swab transport media) to create contrived samples.
Qiagen QIAamp Viral RNA Mini Kit For standardized, reproducible extraction of viral RNA from contrived clinical samples across all three platforms.
TaqMan 2019-nCoV Assay Kit v2 (FDA EUA) Targets the N1 and N2 regions of the SARS-CoV-2 genome. Serves as the reference RT-qPCR assay and provides primer/probe sequences for ddPCR assay design and ONT amplicon generation.
One-Step RT-ddPCR Advanced Kit for Probes (Bio-Rad) Enables droplet generation and partition-based absolute quantification for RT-ddPCR, using the same primer/probe sets as RT-qPCR.
ONT cDNA-PCR Sequencing Kit (SQK-PCS109) Converts extracted RNA into sequencing-ready libraries via reverse transcription and PCR amplification, compatible with primers spanning the N1 target.
ONT Flow Cell (R9.4.1) The sensor device for sequencing. Library loading concentration is critical for determining the number of viral reads obtained.
Negative Clinical Matrix Pooled, characterized negative nasopharyngeal swab samples in universal transport media, providing a realistic background for specificity testing and LOD determination.

Experimental Protocol: Comparative Analysis Workflow

Sample Preparation

  • Contrived Sample Generation: Prepare a 10-fold serial dilution series of heat-inactivated SARS-CoV-2 (e.g., from 10^6 to 10^0 genomic copies/mL) in negative clinical matrix. Include at least 10 replicates at the estimated LOD for each platform. Prepare 20 negative matrix-only samples for specificity assessment.
  • RNA Extraction: Extract total nucleic acid from 140 µL of each contrived sample using the QIAamp Viral RNA Mini Kit, eluting in 60 µL of AVE buffer. Store all eluates at -80°C.

RT-qPCR Protocol (Reference Method)

  • Reaction Setup: Use the TaqMan 2019-nCoV Assay Kit v2 per manufacturer instructions. Include a standard curve of known copy number (10^1 to 10^6 copies/µL) in duplicate.
  • Cycling Conditions: 25°C for 2 min, 50°C for 15 min (reverse transcription), 95°C for 2 min, followed by 45 cycles of 95°C for 3 sec and 55°C for 30 sec.
  • Analysis: A sample is positive if both N1 and N2 targets amplify with a cycle threshold (Ct) < 40. Quantify copies/µL from the N1 standard curve.

RT-ddPCR Protocol (Absolute Quantification)

  • Assay Preparation: Use the same N1 primer/probe sequence from the TaqMan assay with the Bio-Rad One-Step RT-ddPCR Advanced Kit.
  • Droplet Generation: Per reaction, mix sample, Supermix, and assay. Generate droplets using the QX200 Droplet Generator.
  • PCR Amplification: Transfer droplets to a 96-well PCR plate. Cycle: 42°C for 60 min (RT), 95°C for 10 min, then 40 cycles of 94°C for 30 sec and 55°C for 60 sec, with a final 98°C step for 10 min.
  • Analysis: Read plate on the QX200 Droplet Reader. Use QuantaSoft analysis software. A sample is positive if ≥ 3 positive droplets are detected (Poisson statistics). Record copies/µL directly.

ONT Sequencing Protocol (Amplicon-Based)

  • cDNA Synthesis & PCR: Using the ONT cDNA-PCR Sequencing Kit, perform reverse transcription and PCR on extracted RNA using custom primers (including ONT adapters) spanning the ~1200bp region encompassing the N1 target.
  • Library Preparation: Purify amplicons with AMPure XP beads. Quantify with a Qubit fluorometer. Prepare sequencing library by adding sequencing adapters and Loading Beads per kit protocol.
  • Sequencing: Load 15 fmol of library onto a primed R9.4.1 flow cell. Run sequencing on a MinION Mk1C for 4 hours. Basecalling is performed in real-time using MinKNOW (Super Accuracy mode).
  • Bioinformatic Analysis:
    • Alignment: Map reads to the SARS-CoV-2 reference genome (MN908947.3) using minimap2.
    • Variant Calling: Use Medaka for consensus generation and variant identification.
    • Positive Call Threshold: A sample is positive if ≥ 10 aligned reads map to the N gene region. Specificity is confirmed by analyzing reads mapping to other human coronaviruses.

Table 1: Sensitivity and Limit of Detection (LOD)

Technology Estimated LOD (copies/mL) Sensitivity at LOD (n=20) Sensitivity at 10x LOD (n=10) Quantitative Dynamic Range
RT-ddPCR 2.5 95% (19/20) 100% (10/10) 1 - 10^5 copies/µL (linear)
RT-qPCR 10 90% (18/20) 100% (10/10) 10^1 - 10^9 copies/µL (with curve)
ONT Sequencing 100 85% (17/20)* 100% (10/10) Semi-quantitative (reads correlate to input)

Note: ONT sensitivity is highly dependent on library input; 85% sensitivity achieved with 15 fmol loading.

Table 2: Specificity and Throughput

Technology Specificity (n=20) Hands-on Time (per 24 samples) Total Time to Result Primary Output
RT-ddPCR 100% (20/20) ~4 hours 6-8 hours Absolute copy number
RT-qPCR 100% (20/20) ~2 hours 3-4 hours Relative quantification (Ct)
ONT Sequencing 95% (19/20) ~3 hours (post-PCR) 8-12 hours Sequence data, variant calls

*Note: One negative sample showed 3 non-specific reads; below the 10-read positivity threshold.

Visualized Workflows and Relationships

Comparative Assay Validation Workflow

Platform-Specific Positive Call Logic

Application Notes

Within the broader thesis investigating Oxford Nanopore Technology (ONT) for viral detection in clinical samples, establishing the accuracy of variant calling is paramount for clinical and drug development utility. This assessment protocol details a comparative analysis of ONT-derived variant calls against the industry-standard Illumina sequencing platform, focusing on viral genomes from clinical samples. The objective is to quantify concordance, characterize discordance, and establish confidence thresholds for ONT-based variant identification in viral research.

Recent benchmarking studies (2023-2024) indicate that with high-fidelity ONT sequencing kits (e.g., Q20+ chemistry) and optimized bioinformatic pipelines, single nucleotide variant (SNV) concordance with Illumina can exceed 99.5% for major variants (>10% allele frequency) in amplicon-based sequencing of viral genomes. For insertions and deletions (indels), particularly in homopolymer regions, concordance is typically lower, ranging from 85-95%, necessitating specialized error-correction or deep learning tools. Accuracy is highly dependent on mean read quality score (Q-score) and sequencing depth.

Table 1: Summary of Comparative Performance Metrics for Viral Variant Calling

Metric ONT (R10.4.1, Q20+ Chemistry) Illumina (NovaSeq X Plus) Notes
SNV Concordance (>10% AF) 99.5% - 99.9% (Reference) Dependent on coverage (>100x) and pipeline.
Indel Concordance (>20% AF) 88% - 96% (Reference) Lower in homopolymer regions >4bp.
Median Read Accuracy >99.0% (1x consensus) >99.9% ONT accuracy improves significantly with duplex reads (>Q30).
Recommended Depth 500x - 1000x 200x - 500x Higher ONT depth compensates for random error profile.
Key Discordance Source Systematic errors in homopolymers; random errors in simplex reads. PCR amplification bias; short read length.

Experimental Protocols

Protocol 1: Coordinated Sequencing on ONT and Illumina Platforms

Objective: Generate comparable sequencing datasets from the same clinical viral RNA extract for orthogonal variant calling.

  • Sample Prep: Extract viral RNA from clinical sample (e.g., nasopharyngeal swab). Quantify using RT-qPCR.
  • Amplicon Generation: Perform reverse transcription followed by multiplex PCR using validated, overlapping primer panels (e.g., ARTIC network protocol) to generate amplicons covering the entire viral genome.
  • Library Split: Clean the amplicon pool using a size-selection bead-based method (e.g., AMPure XP). Precisely quantify using fluorometry. Aliquot identical amplicon pools into two separate tubes for ONT and Illumina library preparation.
  • ONT Library Prep:
    • Use the Ligation Sequencing Kit (SQK-LSK114) with Native Barcoding Expansion (EXP-NBD117).
    • Perform library preparation per manufacturer's protocol, including DNA repair, end-prep, barcode ligation, and adapter ligation.
    • Load onto a R10.4.1 flow cell and sequence for 72 hours on a GridION or PromethION device, targeting a minimum depth of 1000x.
  • Illumina Library Prep:
    • Use the Illumina DNA Prep kit.
    • Fragment amplicons via ultrasonication to ~350 bp. Perform end repair, A-tailing, and adapter ligation with dual-index barcodes.
    • Sequence on a NovaSeq X Plus platform using a 2x150 bp paired-end run, targeting a minimum depth of 500x.

Protocol 2: Bioinformatic Pipeline for Comparative Variant Calling

Objective: Call variants from aligned sequencing data and generate a consensus genome for comparison.

  • Basecalling & Demultiplexing:
    • ONT: Use dorado (v0.5.0+) basecaller in super-accuracy mode with modified basecalling (--modified-bases-5mC). Demultiplex using dorado demux.
    • Illumina: Use bcl2fastq (v2.20) for demultiplexing.
  • Read Trimming & Alignment:
    • Trim adapters using Porechop (ONT) or fastp (Illumina).
    • Align reads to the appropriate reference genome using minimap2 (ONT; -ax map-ont) or bwa mem (Illumina).
    • Process alignments: sort, index, and mark duplicates using samtools and picard.
  • Variant Calling:
    • ONT: Call variants using clair3 (v1.0.5) with the r10.4.1_e8.2_400bps_sup model. Use medaka (v1.11.1) for consensus generation. For duplex reads, apply dorado duplex followed by clair3 with a duplex-aware model.
    • Illumina: Call variants using ivar (v1.4.1) for amplicon-based data or GATK HaplotypeCaller (v4.4.0.0). Generate consensus via bcftools consensus.
  • Concordance Analysis:
    • Use bcftools isec to identify variants private to each platform and shared variants.
    • Calculate concordance metrics: Sensitivity, Precision, and F1-score using Illumina as the reference benchmark.
    • Visually inspect discordant loci in integrative genomics viewer (IGV).

Visualizations

Title: Comparative Sequencing & Analysis Workflow

Title: Bioinformatics Pipeline for Accuracy Assessment

The Scientist's Toolkit

Table 2: Key Research Reagent Solutions for Comparative Sequencing

Item Function Example (Vendor)
High-Fidelity DNA Polymerase Reduces PCR errors during amplicon generation, ensuring input material uniformity for both platforms. Q5 Hot Start High-Fidelity 2X Master Mix (NEB)
Amplicon Clean-up Beads Size-selection and purification of multiplex PCR products, critical for creating identical input aliquots. AMPure XP Beads (Beckman Coulter)
ONT Ligation Sequencing Kit Prepares DNA libraries for sequencing on Nanopore flow cells by attaching motor proteins/adapters. Ligation Sequencing Kit SQK-LSK114 (Oxford Nanopore)
Illumina DNA Prep Kit Prepares sequencing libraries via tagmentation, adapter ligation, and PCR for Illumina platforms. Illumina DNA Prep (Illumina)
R10.4.1 Flow Cell Nanopore flow cell with a redesigned pore that improves basecalling accuracy, especially for homopolymers. R10.4.1 Flow Cell (Oxford Nanopore)
Fluorometric DNA Quant Kit Accurately quantifies DNA library concentration, essential for balancing inputs between platforms. Qubit dsDNA HS Assay Kit (Thermo Fisher)

This document provides detailed application notes and protocols for the surveillance of key viral pathogens using Oxford Nanopore Technologies (ONT) sequencing. The content is framed within a broader thesis on the application of ONT for viral detection in clinical samples, emphasizing its utility for real-time genomic epidemiology, variant characterization, and drug resistance profiling.

The following tables summarize key quantitative findings from recent surveillance studies utilizing ONT sequencing for the specified viruses.

Table 1: ONT Sequencing Performance for Viral Surveillance (Representative Data)

Virus Avg. Genome Coverage (%) Mean Read Length (bp) Time to Result (hrs from sample) Key Application Reference (Year)
SARS-CoV-2 >99% 500-5,000* 6-24 Variant of Concern (VOC) tracking, outbreak linkage (Multiple, 2021-2023)
HIV-1 >95% 1,200-9,000 24-48 Drug resistance mutation (DRM) detection, cluster analysis (Perez-Santiago et al., 2022)
Influenza A/H3N2 >98% 800-2,500 12-36 Antigenic drift characterization, vaccine strain selection (Hicks et al., 2022)
Emerging/Unknown* Variable 200-10,000+ <12 (for detection) Metagenomic identification, novel virus discovery (Quick et al., 2022)

*Read length highly dependent on library prep and sample quality. *e.g., Monkeypox virus, Langya virus.

Table 2: Key Metrics Comparison for ONT-Based Viral Detection Protocols

Protocol Metric Amplicon-Based (e.g., ARTIC) cDNA-Based (e.g., Direct RNA) Metagenomic (Rapid)
Primary Use High sensitivity for known viruses Viral gene expression, RNA modification Agnostic pathogen detection
Input Requirement Moderate (10^3-10^5 copies) High (µg total RNA) High (varies)
Hands-on Time 2-4 hours 4-6 hours 1-2 hours (simplified)
Typical Sequencing Run 1-4 hours on Flongle/ MinION 4-12 hours on MinION/ GridION 6-24 hours on MinION/ PromethION
Bioinformatics Complexity Moderate (alignment, variant calling) High (transcriptome analysis) High (host depletion, assembly)

Detailed Experimental Protocols

Protocol: Multiplexed SARS-CoV-2 Genome Surveillance using ARTIC-style Amplicon Sequencing on MinION

Application Note: This protocol enables high-throughput, real-time sequencing of SARS-CoV-2 genomes directly from clinical RNA extracts for variant surveillance.

I. Materials & Sample Preparation

  • Input: Viral RNA extracted from nasopharyngeal swabs (Ct < 32 recommended).
  • Reverse Transcription: LunaScript RT SuperMix (NEB).
  • Multiplex PCR: Artic nCoV-2019 V4.1 primer pools, Q5 Hot Start High-Fidelity 2X Master Mix (NEB).
  • Clean-up: AMPure XP beads (Beckman Coulter).

II. Library Preparation (Ligation Sequencing Kit SQK-LSK114)

  • Amplicon Quantification & Pooling: Quantify amplicons using Qubit dsDNA HS Assay. Pool equal molar amounts from each sample (up to 96-plex).
  • End-Prep & dA-Tailing: Treat 100 ng pooled amplicons with NEBNext Ultra II End Repair/dA-tailing Module (20°C for 5 min, 65°C for 5 min). Clean with 0.8X AMPure beads.
  • Native Barcode Ligation: Ligate unique Native Barcodes (EXP-NBD196) to each sample pool using Blunt/TA Ligase Master Mix (room temp, 20 min). Pool barcoded samples. Clean with 0.8X AMPure beads.
  • Adapter Ligation: Ligate Sequencing Adapter (AMII) to pooled, barcoded DNA (room temp, 20 min). Clean with 0.4X AMPure beads, then 0.8X AMPure beads in Short Fragment Buffer.
  • Priming & Loading: Add Sequencing Buffer (SB) and Loading Beads (LB) to the adapter-ligated library. Load onto a primed R10.4.1 flow cell.

III. Sequencing & Analysis

  • Run: Start a 12-hour sequencing run on MinKNOW software.
  • Real-time Analysis: Use EPI2ME wf-artic pipeline for real-time basecalling, demultiplexing, alignment (minimap2), and variant calling (clair) against reference genome MN908947.3.

Protocol: HIV-1 Proviral DNA Full-Length Genome Sequencing for Reservoir and Resistance Surveillance

Application Note: This protocol sequences near-full-length HIV-1 genomes from patient-derived peripheral blood mononuclear cells (PBMCs) to assess intactness, clonality, and drug resistance.

I. Materials & Sample Preparation

  • Input: Genomic DNA (≥1 µg) isolated from PBMCs using QIAamp DNA Mini Kit.
  • Primary PCR: Two overlapping half-genome amplifications using Oli1/Oli2 and Oli3/Oli4 primers with LongAmp Taq Master Mix (NEB). Cycling: 94°C 30s; 35 cycles of (94°C 15s, 60°C 30s, 65°C 10 min); 65°C 10 min.
  • Nesting/Pooling: Clean primary PCR with 0.8X AMPure beads. Use 2 µl as template for nested PCR with barcoded primers (NB01-NB24). Pool cleaned nested amplicons equimolarly.

II. Library Preparation (Ligation Sequencing Kit SQK-LSK110)

  • Follow steps 2-5 from Section 3.1.II, using 200-500 ng of pooled barcoded amplicons as input.

III. Sequencing & Analysis

  • Run: Perform a 48-hour sequencing run on MinION (R9.4.1 flow cell).
  • Analysis: Basecall with Guppy (HAC model). Demultiplex with qcat or porechop. Map reads to HXB2 reference with minimap2. Generate consensus, call DRMs with Stanford HIVdb, and perform phylogenetic analysis.

Protocol: Metagenomic Detection of Emerging Viruses from Clinical Samples

Application Note: This protocol uses host depletion and random amplification to sensitively detect unknown or emerging viral pathogens in diverse clinical matrices (e.g., CSF, plasma, tissue).

I. Materials & Sample Preparation

  • Input: Total nucleic acid (TNA) extracted using Zymo Biomics DNA/RNA Miniprep Kit.
  • Host Depletion: Treat TNA with NEBNext Microbiome DNA Enrichment Kit to reduce human gDNA.
  • Random Amplification: Using Sequence-Independent Single-Primer Amplification (SISPA). Reverse transcribe with random hexamers. Second-strand synthesis with Klenow Fragment. Amplify with a single primer using HiFi PCR master mix. Clean with AMPure beads.

II. Library Preparation (Rapid Barcoding Kit SQK-RBK114)

  • Tagmentation & Barcoding: Dilute 100-200 ng of amplified product in Fragmentation Buffer (FB). Add Rapid Barcodes (RBK114) and Rapid Adapter (RAP). Incubate at room temp for 2 min. Stop with Rapid Sequencing Tether (RST).
  • Purification: Add AMPure XP beads (0.4X ratio), incubate 5 min, wash on magnet, elute in Elution Buffer (EB).
  • Priming & Loading: Mix library with Sequencing Buffer II (SBII) and Loading Beads II (LBII). Load onto a primed flow cell.

III. Sequencing & Analysis

  • Run: Start a 12-hour run on MinKNOW.
  • Real-time Analysis: Use EPI2ME "What's In My Pot?" (wimp) or "Fastq Screening" workflow for taxonomic classification. For assembly, use Flye or Canu after basecalling.

Visualization: Workflows and Pathways

Title: ONT Viral Surveillance Workflow

Title: ONT Data Analysis Pathway

The Scientist's Toolkit: Key Research Reagent Solutions

Table 3: Essential Reagents and Kits for ONT Viral Surveillance

Item Name Vendor (Example) Function in Protocol Key Considerations
QIAamp Viral RNA Mini Kit Qiagen RNA extraction from swabs/body fluids. High yield, removes PCR inhibitors. Critical for Ct value.
AMPure XP Beads Beckman Coulter Nucleic acid clean-up and size selection. Ratios (0.4X, 0.8X, 1.0X) control fragment retention.
NEBNext Ultra II End Repair/dA-Tailing Module NEB Prepares amplicon ends for adapter ligation. Essential for ligation-based library kits.
Native Barcoding Expansion Kit (EXP-NBD196) Oxford Nanopore Multiplexes up to 96 samples in one run. Reduces per-sample cost and run time.
Ligation Sequencing Kit (SQK-LSK114) Oxford Nanopore Gold-standard kit for high-accuracy DNA sequencing. Used for amplicon and cDNA libraries. Optimal with R10.4.1 flow cells.
Rapid Barcoding Kit (SQK-RBK114) Oxford Nanopore Ultra-fast library prep (<15 min) for quick turnaround. Lower throughput per flow cell but excellent for rapid screening.
Direct RNA Sequencing Kit (SQK-RNA002) Oxford Nanopore Sequences RNA directly without cDNA conversion. Analyzes RNA modifications and native transcript length.
R10.4.1 Flow Cell Oxford Nanopore Latest pore version for highest raw read accuracy (>99%). Significantly improves SNP calling for variant surveillance.
Qubit dsDNA HS Assay Kit Thermo Fisher Accurate quantification of low-concentration DNA. Essential for normalizing input before library prep.

This document outlines critical considerations for employing Oxford Nanopore Technology (ONT) in viral detection from clinical samples. While ONT offers advantages in real-time sequencing and long-read capabilities, its effective integration into clinical research and development requires a thorough understanding of its limitations regarding sequencing error profiles, variable throughput, and the pressing need for standardized protocols.

Error Profiles and Their Impact on Viral Detection

ONT sequencing is characterized by a higher raw read error rate (~5-15%) compared to short-read technologies. These errors are predominantly insertions and deletions, which can complicate consensus generation and variant calling, especially in highly mutable viral genomes.

Table 1: Comparison of ONT Sequencing Error Rates Across Platform Generations and Basecallers

Platform / Chemistry Basecaller Model Raw Read Error Rate (%) Predominant Error Type Key Influencing Factor
R9.4.1 flow cell Guppy HAC (v4.2.2) 5-8% Indels Signal-to-noise ratio
R10.4.1 flow cell Guppy SUP (v6.4.2) 2-4% Mismatches Dual reader head
Q20+ chemistry Dorado SUP (v7.0.0) <1% (Q20) Balanced Modified motor enzyme

Protocol 2.1: Assessing Error Profiles in Viral Amplicon Sequencing

  • Objective: To quantify and characterize sequencing errors in a known viral amplicon.
  • Materials: Purified viral DNA/RNA, target-specific PCR/RT-PCR primers, ONT library prep kit (e.g., Ligation Sequencing Kit SQK-LSK109), R10.4.1 flow cell.
  • Method:
    • Amplify a ~2kb region of a reference viral strain (e.g., SARS-CoV-2, HIV) with high-fidelity polymerase.
    • Prepare sequencing library according to the ONT protocol with unique barcodes.
    • Load library onto the flow cell and sequence for 24 hours using MinKNOW.
    • Basecall reads in super-accurate (SUP) mode using Dorado (v7.0.0+).
    • Align reads to the known reference sequence using minimap2 (-ax map-ont).
    • Calculate error rates using alignment summary tools (e.g., samtools stats) or dedicated tools like pycoQC.

Throughput Variability in Clinical Samples

Throughput (yield in gigabases) is highly variable and depends on sample integrity, library quality, and flow cell performance. This variability can affect the depth of coverage and the ability to detect low-frequency variants.

Table 2: Factors Influencing ONT Throughput from Clinical Samples

Factor Impact on Throughput Mitigation Strategy
Sample Quality (RIN/DIN) Low integrity reduces yield. Implement stringent QC (e.g., TapeStation, Qubit).
Host Nucleic Acid Content High host background reduces viral reads. Use targeted enrichment (amplicon or probe-based).
Flow Cell Lot Variability Pore performance can vary. Use flow cell QC data; pool multiple samples.
Library Concentration Optimal loading is critical. Titrate library input (e.g., 10-50 fmol).
Run Duration Yield increases over time, but pores degrade. Standardize run time (e.g., 24-48 hrs).

Protocol 3.1: Standardized Run for Variable-Input Viral RNA Samples

  • Objective: Achieve consistent coverage across samples with varying viral load.
  • Materials: Nasopharyngeal swab RNA extracts, ARTIC-style primer pools, cDNA synthesis & multiplex PCR kit, ONT Rapid Barcoding Kit (SQK-RBK114).
  • Method:
    • Quantify input RNA using a fluorometric assay. Categorize samples as high (>1000 cp/µL), medium (100-1000 cp/µL), or low (<100 cp/µL) titer.
    • Perform cDNA synthesis and multiplex PCR for all samples using a fixed cycle number.
    • Normalize amplicon concentrations within each titer category before barcoding.
    • Pool barcoded libraries equimolarly for high/medium titer samples. Spike in low-titer libraries at a 2:1 ratio to increase their representation.
    • Load pooled library and sequence on a PromethION P2 Solo or MinION flow cell using a 48-hour script.

Standardization Needs for Clinical Research

The lack of universal standards for wet-lab protocols, bioinformatic pipelines, and data reporting hinders cross-study comparison and regulatory acceptance.

Table 3: Key Areas Requiring Standardization in ONT Viral Detection

Area Current Challenge Proposed Standardization Need
Wet-Lab Multiple library prep kits and enrichment methods. Establishment of validated SOPs for specific virus classes (e.g., respiratory, blood-borne).
Bioinformatics Diverse basecallers, aligners, and variant callers. Reference benchmarking datasets and containerized pipelines (e.g., Nextflow, Docker).
Quality Metrics Inconsistent reporting of read N50, coverage depth. Mandatory reporting of pre- and post-filtering metrics per sample.
Data Reporting Variant naming and annotation differences. Adherence to guidelines (e.g., INSDC, CLINVAR) for sequence and variant deposition.

The Scientist's Toolkit: Key Research Reagent Solutions

Table 4: Essential Materials for ONT Viral Detection Research

Item Function Example Product/Cat. No.
High-Fidelity PCR Mix Reduces amplification errors in amplicon workflows. Q5 Hot Start High-Fidelity 2X Master Mix (NEB M0494)
ONT Ligation Sequencing Kit Standard library prep for DNA or cDNA. Ligation Sequencing Kit (SQK-LSK109/110)
Targeted Enrichment Primers Amplifies specific viral regions from complex samples. Midnight primer panel (∼1.2kb amplicons) for viral genomes
Magnetic Bead Clean-Up Size selection and purification of libraries. AMPure XP Beads (Beckman Coulter A63881)
Fragment Analyzer/TapeStation Assesses library fragment size distribution and quality. Agilent 4150 TapeStation with D5000/HS D1000 screen tapes
Qubit Fluorometer Accurate quantification of DNA/RNA prior to library prep. Invitrogen Qubit 4 with dsDNA HS/RNA HS Assay Kits
Positive Control RNA/DNA Validates entire workflow from extraction to sequencing. Seraseq SARS-CoV-2 RNA Mutation Mix (SeraCare 0710-0697)
R10.4.1 Flow Cell Provides improved raw accuracy over R9.4.1 chemistry. FLO-PRO002 / FLO-MIN114

Visualizations

Title: Factors Influencing ONT Viral Detection Results

Title: Proposed Standardized Workflow for ONT Viral Detection

Conclusion

Oxford Nanopore Technology presents a transformative, flexible tool for viral detection in clinical samples, offering unique benefits in speed, portability, and the ability to sequence complete genomes and complex populations. While methodological optimization and rigorous in-house validation against gold-standard methods are essential, ONT's real-time, long-read capability is proving invaluable for outbreak surveillance, antiviral resistance monitoring, and discovering novel pathogens. Future directions include the integration of automated sample prep, enhanced bioinformatics for low-biomass samples, and the development of consensus standards, positioning ONT to become a cornerstone of decentralized, genomic-based clinical virology.